Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

xQuarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

xQuarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarterly period ended SeptemberMarch 28, 20192020

 

oTransition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

oTransition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from                 to

 

Commission file number: 001-33346

 

Summer Infant, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

20-1994619

(State or other jurisdiction

(IRS Employer Identification No.)

of incorporation or organization)

 

1275 Park East Drive

Woonsocket, RI 02895

(401) 671-6550

(Address of principal executive offices) (Zip Code)

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.0001

SUMR

Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer o

Accelerated filer o

Non-accelerated filer x

Smaller reporting company x

Emerging growth companyo

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

 

As of November 7, 2019,May 3, 2020, there were 18,941,4592,111,427 shares outstanding of the registrant’sregistrant���s Common Stock, $0.0001 par value per share.

 

 


Summer Infant, Inc.

Form 10-Q

Table of Contents

Summer Infant, Inc.

Form 10-Q

Table of Contents

 

Page Number

Part I.

Financial Information

1

Item 1.

Condensed Consolidated Financial Statements (unaudited)

1

Condensed Consolidated Balance Sheets as of SeptemberMarch 28, 20192020 (unaudited) and December 29, 201830, 2019

1

Condensed Consolidated Statements of Operations for the Three and Nine Months Ended SeptemberMarch 28, 2020 and March 30, 2019 and September 29, 2018 (unaudited)

2

Condensed Consolidated Statements of Comprehensive Loss for the Three and Nine Months Ended SeptemberMarch 28, 2020 and March 30, 2019 and September 29, 2018 (unaudited)

3

Condensed Consolidated Statements of Cash Flows for the NineThree Months Ended SeptemberMarch 28, 2020 and March 30, 2019 and September 29, 2018 (unaudited)

4

Condensed Consolidated Statements of Stockholder’sStockholder’ Equity for the NineThree Months Ended SeptemberMarch 28, 2020 and March 30, 2019 and September 29, 2018 (unaudited)

5

Notes to Condensed Consolidated Financial Statements

6

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

14

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

19

18

Item 4.

Controls and Procedures

19

18

Part II.

Other Information

20

19

Item 1.

Legal Proceedings

20

19

Item 1A.

Risk Factors

20

19

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

20

19

Item 3.

Defaults Upon Senior Securities

20

19

Item 4.

Mine Safety Disclosures

20

Item 5.

Other Information

20

Item 6.

Exhibits

20

Exhibit Index

21

Signatures

22

23

 


Table of Contents

 

PART I.  FINANCIAL INFORMATION

 

ITEM 1.Condensed Consolidated Financial Statements (unaudited)

ITEM 1.Condensed Consolidated Financial Statements (unaudited)

 

Summer Infant, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

 

Note that all amounts presented in the table below are in thousands of U.S. dollars, except share and par value amounts.

 

 

(Unaudited)

 

 

 

 (Unaudited)    

 

September 28,
2019

 

December 29,
2018

 

 March 28,
2020
  December 28,
2019
 

ASSETS

 

 

 

 

 

        

 

 

 

 

 

        

CURRENT ASSETS

 

 

 

 

 

        

 

 

 

 

 

        

Cash and cash equivalents

 

$

659

 

$

721

 

 $693  $395 

Trade receivables, net of allowance for doubtful accounts

 

29,676

 

31,223

 

  30,471   32,787 

Inventory, net

 

30,160

 

36,066

 

  25,170   28,056 

Prepaid and other current assets

 

1,315

 

997

 

  3,034   2,946 

TOTAL CURRENT ASSETS

 

61,810

 

69,007

 

  59,368   64,184 

Property and equipment, net

 

9,102

 

9,685

 

  8,118   8,788 

Other intangible assets, net

 

13,027

 

13,300

 

  12,799   12,896 

Right to use assets, noncurrent

 

4,842

 

 

  3,959   4,578 

Deferred tax assets, net

 

2,128

 

2,127

 

  1,243   996 

Other assets

 

100

 

97

 

  94   101 

TOTAL ASSETS

 

$

91,009

 

$

94,216

 

 $85,581  $91,543 

 

 

 

 

 

        

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

        

 

 

 

 

 

        

CURRENT LIABILITIES

 

 

 

 

 

        

 

 

 

 

 

        

Accounts payable

 

$

24,480

 

$

28,120

 

 $25,530  $25,396 

Accrued expenses

 

6,439

 

8,939

 

  7,446   7,289 

Lease liabilities, current

 

2,324

 

 

  2,523   2,495 

Current portion of long term debt

 

875

 

875

 

  219   875 

TOTAL CURRENT LIABILITIES

 

34,118

 

37,934

 

  35,718   36,055 

Long-term debt, less current portion and unamortized debt issuance costs

 

45,468

 

44,641

 

  41,759   45,359 

Lease liabilities, noncurrent

 

3,034

 

 

  1,844   2,546 

Other liabilities

 

2,064

 

2,371

 

  1,953   2,000 

TOTAL LIABILITIES

 

84,684

 

84,946

 

  81,274   85,960 

 

 

 

 

 

        

STOCKHOLDERS’ EQUITY

 

 

 

 

 

        

Preferred Stock, $0.0001 par value, 1,000,000 authorized, none issued or outstanding at September 28, 2019 and December 29, 2018, respectively

 

 

 

Common Stock $0.0001 par value, authorized, issued and outstanding of 49,000,000, 19,213,108 and 18,941,459 at September 28, 2019 and 49,000,000, 19,092,251, and 18,820,602 at December 29, 2018, respectively

 

2

 

2

 

Treasury Stock at cost (271,649 shares at September 28, 2019 and December 29, 2018)

 

(1,283

)

(1,283

)

Preferred Stock, $0.0001 par value, 1,000,000 authorized, none issued or outstanding at March 28, 2020 and December 28, 2019, respectively      
Common Stock $0.0009 par value, authorized, issued and outstanding of 5,444,445, 2,141,612 and 2,111,427 at March 28, 2020 and 5,444,445, 2,138,928, and 2,108,743 at December 28, 2019, respectively  2   2 
Treasury Stock at cost (30,185 shares at March 28, 2020 and December 28, 2019)  (1,283)  (1,283)

Additional paid-in capital

 

77,620

 

77,396

 

  77,704   77,715 

Accumulated deficit

 

(67,167

)

(63,885

)

  (70,298)  (69,088)

Accumulated other comprehensive loss

 

(2,847

)

(2,960

)

  (1,818)  (1,763)

TOTAL STOCKHOLDERS’ EQUITY

 

6,325

 

9,270

 

  4,307   5,583 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

 

$

91,009

 

$

94,216

 

 $85,581  $91,543 

 

See notes to condensed consolidated financial statements

1

Summer Infant, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

 

Note that all amounts presented in the table below are in thousands of U.S. dollars, except share and per share amounts.

 

 

Unaudited

 

Unaudited

 

 (Unaudited) 

 

For the three months ended

 

For the nine months ended

 

 For the Three Months Ended 

 

September 28,
2019

 

September 29,
2018

 

September 28,
2019

 

September 29,
2018

 

 March 28,
2020
  March 30,
2019
 

Net sales

 

$

41,523

 

$

43,838

 

$

130,486

 

$

133,571

 

 $40,338  $42,538 

Cost of goods sold

 

28,928

 

30,227

 

89,599

 

90,974

 

  27,835   29,088 

Gross profit

 

12,595

 

13,611

 

40,887

 

42,597

 

  12,503   13,450 

General & administrative expenses

 

8,353

 

7,623

 

26,255

 

29,587

 

Selling expenses

 

3,597

 

3,658

 

10,981

 

9,427

 

General and administrative expenses  8,147   9,379 
Selling expense  3,444   3,353 

Depreciation and amortization

 

919

 

1,012

 

2,808

 

3,087

 

  967   937 

Operating (loss) income

 

(274

)

1,318

 

843

 

496

 

Operating loss  (55)  (219)

Interest expense, net

 

1,191

 

1,118

 

3,733

 

3,300

 

  1,410   1,249 

(Loss) income before provision (benefit) for income taxes

 

(1,465

)

200

 

(2,890

)

(2,804

)

Provision (benefit) for income taxes

 

195

 

82

 

392

 

(513

)

Net (loss) income

 

$

(1,660

)

$

118

 

$

(3,282

)

$

(2,291

)

Net (loss) income per share:

 

 

 

 

 

 

 

 

 

Loss before income taxes  (1,465)  (1,468)
Benefit for income taxes  (255)  (70)
NET LOSS $(1,210) $(1,398)
Net loss per share:        

BASIC

 

$

(0.09

)

$

0.01

 

$

(0.17

)

$

(0.12

)

 $(0.57) $(0.67)

DILUTED

 

$

(0.09

)

$

0.01

 

$

(0.17

)

$

(0.12

)

 $(0.57) $(0.67)

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

        

BASIC

 

18,937,860

 

18,788,650

 

18,889,969

 

18,723,477

 

  2,109,264   2,092,574 

DILUTED

 

18,937,860

 

18,878,112

 

18,889,969

 

18,723,477

 

  2,109,264   2,092,574 

 

See notes to condensed consolidated financial statements.

2

Summer Infant, Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Loss

 

Note that all amounts presented in the table below are in thousands of U.S. dollars.

 

 

Unaudited
For the three
months ended

 

Unaudited
For the nine
months ended

 

 (Unaudited) 

 

September 28,
2019

 

September 29,
2018

 

September 28,
2019

 

September 29,
2018

 

 For The Three Months
Ended
 

Net (loss) income

 

$

(1,660

)

$

118

 

$

(3,282

)

$

(2,291

)

 March 28, 2020  March 30, 2019 
Net loss $(1,210) $(1,398)

Other comprehensive (loss) income:

 

 

 

 

 

 

 

 

 

        

Changes in foreign currency translation adjustments

 

(100

)

95

 

113

 

(305

)

  (55)  165 

 

 

 

 

 

 

 

 

 

        

Comprehensive net (loss) income

 

$

(1,760

)

$

213

 

$

(3,169

)

$

(2,596

)

Comprehensive loss $(1,265) $(1,233)

 

See notes to condensed consolidated financial statements.

3

Summer Infant, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

 

Note that all amounts presented in the table below are in thousands of U.S. dollars.

 

 

(Unaudited)

 

 (Unaudited) 

 

For the nine months ended

 

 For the three months ended 

 

September 28,
2019

 

September 29,
2018

 

 March 28,
2020
 March 30,
2019
 

Cash flows from operating activities:

 

 

 

 

 

     

Net loss

 

$

(3,282

)

$

(2,291

)

 $(1,210)$(1,398)

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

 

 

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:     

Depreciation and amortization

 

2,808

 

3,087

 

 967 904 

Stock-based compensation expense

 

224

 

433

 

Stock-based compensation expense, net of forfeitures (11)48 
Provision for allowance for doubtful accounts 23 9 

Write off of unamortized deferred financing costs

 

 

518

 

 266  

Provision for allowance for doubtful accounts

 

21

 

1,496

 

Non cash lease expense

 

1,569

 

 

Amortization of right of use assets 619 496 

Changes in assets and liabilities:

 

 

 

 

 

     

Decrease (Increase) in trade receivables

 

1,666

 

(2,418

)

Decrease (increase) in trade receivables 2,099 (3,198) 

Decrease in inventory

 

6,098

 

6,474

 

 2,692 2,273 
Decrease in lease liabilities (673)(532)

Increase in prepaids and other assets

 

(351

)

(359

)

 (49)(313)

Decrease in lease liability

 

(1,053

)

 

Decrease in accounts payable and accrued expenses

 

(6,558

)

(1,496

)

Net cash provided by operating activities

 

1,142

 

5,444

 

Increase (decrease) in accounts payable and accrued expenses 164 (5,808)
Net cash provided by (used in) operating activities 4,887 (7,519) 

Cash flows from investing activities:

 

 

 

 

 

     

Acquisitions of property and equipment

 

(1,632

)

(2,644

)

 (220)(748)

Acquisitions of other intangible assets

 

(281

)

 

Acquisitions of intangible assets (25)(64) 

Net cash used in investing activities

 

(1,913

)

(2,644

)

 (245)(812)

Cash flows from financing activities:

 

 

 

 

 

     

Proceeds from issuance of common stock upon exercise of stock options

 

 

25

 

Repayment of Prior Term Loan Facility

 

 

(5,000

)

Repayment of Prior FILO

 

 

(1,250

)

Payment of financing fees and expenses

 

 

(1,958

)

Proceeds from New Term Loan Facility

 

 

17,500

 

Repayment of Term Loan Facility

 

(656

)

 

Net borrowings (repayment) on revolving facilities

 

1,484

 

(11,871

)

Net cash provided by (used in) financing activities

 

828

 

(2,554

)

Repayment of term loan facility  (219) 
Net (repayments) borrowings on revolving facility (4,523)8,891 
Net cash (used in) provided by financing activities (4,523)8,672 

Effect of exchange rate changes on cash and cash equivalents

 

(119

)

132

 

 179 (146) 

Net (decrease) increase in cash and cash equivalents

 

(62

)

378

 

Net increase in cash and cash equivalents 298 195 

Cash and cash equivalents, beginning of period

 

721

 

681

 

 395 721 

Cash and cash equivalents, end of period

 

$

659

 

$

1,059

 

 $693 $916 

Supplemental disclosure of cash flow information:

 

 

 

 

 

     

Cash paid for interest

 

$

2,878

 

$

2,207

 

 $877 $986 

Cash paid for income taxes

 

$

5

 

$

4

 

 $2 $3 

 

See notes to condensed consolidated financial statements.

4

Summer Infant, Inc. and Subsidiaries

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)

 

Note that all amounts presented in the table below are in thousands of U.S. dollars, except share and per share data.

 

 

 

Common Stock

 

Additional
Paid in

 

Treasury

 

Accumulated

 

Accumulated
Comprehensive

 

Total

 

 

 

Shares

 

Amount

 

Capital

 

Stock

 

Deficit

 

Loss

 

Equity

 

Balance at December 30, 2017

 

18,629,737

 

$

2

 

$

76,848

 

$

(1,283

)

$

(59,634

)

$

(2,291

)

$

13,642

 

Issuance of common stock upon vesting of restricted shares

 

55,500

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

 

 

 

99

 

 

 

 

 

 

 

99

 

Net loss for the period

 

 

 

 

 

 

 

 

 

(2,707

)

 

 

(2,707

)

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

(52

)

(52

)

Balance at March 31, 2018

 

18,685,237

 

$

2

 

$

76,947

 

$

(1,283

)

$

(62,341

)

$

(2,343

)

$

10,982

 

Issuance of common stock upon vesting of restricted shares

 

67,728

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock upon exercise of stock options

 

16,050

 

 

 

20

 

 

 

 

 

 

 

20

 

Stock-based compensation

 

 

 

 

 

215

 

 

 

 

 

 

 

215

 

Net income for the period

 

 

 

 

 

 

 

 

 

298

 

 

 

298

 

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

(348

)

(348

)

Balance at June 30, 2018

 

18,769,015

 

$

2

 

$

77,182

 

$

(1,283

)

$

(62,043

)

$

(2,691

)

$

11,167

 

Issuance of common stock upon vesting of restricted shares

 

22,847

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock upon exercise of stock options

 

4,500

 

 

 

5

 

 

 

 

 

 

 

5

 

Stock-based compensation

 

 

 

 

 

119

 

 

 

 

 

 

 

119

 

Net income for the period

 

 

 

 

 

 

 

 

 

118

 

 

 

118

 

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

95

 

95

 

Balance at September 28, 2018

 

18,796,362

 

$

2

 

77,306

 

(1,283

)

(61,925

)

(2,596

)

11,504

 

  Common Stock Additional
Paid in
 Treasury Accumulated Accumulated
Comprehensive
 Total 
  Shares Amount Capital Stock Deficit Loss Equity 
Balance at December 29, 2018 2,091,178 $2 $77,396 $(1,283)$(64,924)$(1,921)$9,270 
Issuance of common stock upon vesting of restricted shares 6,167             
Stock-based compensation, net of forfeitures     48       48 
Net loss for the year         (1,398)  (1,398)
Foreign currency translation adjustment           165 165 
Balance at March 30, 2019 2,097,345 $2 $77,444 $(1,283)$(66,322)$(1,756)$8,085 
Balance at December 28, 2019 2,108,743 $2 $77,715 $(1,283)$(69,088)$(1,763)$5,583 
Issuance of common stock upon vesting of restricted shares 1,064             
Fractional Share Issuance upon reverse stock split 1,620             
Stock-based compensation, net of forfeitures     (11)      (11)
Net loss for the period         (1,210)  (1,210)
Foreign currency translation adjustment           (55)(55)
Balance at March 28, 2020 2,111,427 $2 $77,704 $(1,283)$(70,298)$(1,818)$4,307 

 

 

 

Common Stock

 

Additional
Paid in

 

Treasury

 

Accumulated

 

Accumulated
Comprehensive

 

Total

 

 

 

Shares

 

Amount

 

Capital

 

Stock

 

Deficit

 

Loss

 

Equity

 

Balance at December 29, 2018

 

18,820,602

 

$

2

 

$

77,396

 

$

(1,283

)

$

(63,885

)

$

(2,960

)

$

9,270

 

Issuance of common stock upon vesting of restricted shares

 

33,125

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

 

 

 

48

 

 

 

 

 

 

 

48

 

Net loss for the period

 

 

 

 

 

 

 

 

 

(1,398

)

 

 

(1,398

)

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

165

 

165

 

Balance at March 30, 2019

 

18,853,727

 

$

2

 

$

77,444

 

$

(1,283

)

$

(65,283

)

$

(2,795

)

$

8,085

 

Issuance of common stock upon vesting of restricted shares

 

72,977

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

 

 

 

104

 

 

 

 

 

 

 

104

 

Net loss for the period

 

 

 

 

 

 

 

 

 

(224

)

 

 

(224

)

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

48

 

48

 

Balance at June 29, 2019

 

18,926,704

 

$

2

 

$

77,548

 

$

(1,283

)

$

(65,507

)

$

(2,747

)

$

8,013

 

Issuance of common stock upon vesting of restricted shares

 

14,755

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

 

 

 

72

 

 

 

 

 

 

 

72

 

Net loss for the period

 

 

 

 

 

 

 

 

 

(1,660

)

 

 

(1,660

)

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

(100

)

(100

)

Balance at September 28, 2019

 

18,941,459

 

$

2

 

77,620

 

(1,283

)

(67,167

)

(2,847

)

6,325

 

See notes to condensed consolidated financial statements.

5

SUMMER INFANT, INC.  AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1.BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

1.BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

 

The Company designs, markets and distributes branded juvenile health, safety and wellness products that are sold globally to large national retailers as well as independent retailers, primarily in North America. The Company currently markets its products in several product categories including safety, nursery, monitoring, and baby gear. Most products are sold under our core brand names of Summer™, SwaddleMe®, and born freeTM®. When used herein, the terms the “Company,” “we,” “us,” and “our” mean Summer Infant, Inc. and its consolidated subsidiaries.

 

Basis of Presentation and Principles of Consolidation

 

The accompanying interim condensed consolidated financial statements of the Company are unaudited, but in the opinion of management, reflect all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of the results for the interim periods. Accordingly, they do not include all information and notes required by generally accepted accounting principles in the United States of America (“GAAP”) for complete financial statements. The results of operations for interim periods are not necessarily indicative of results to be expected for the entire fiscal year or any other period. The balance sheet at December 29, 201828, 2019 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by GAAP for complete financial statements. These interim condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and notes for the year ended December 29, 201828, 2019 included in its Annual Report on Form 10-K filed with the SEC on February 20, 2019,March 18, 2020, as amended on March 22, 2019.April 24, 2020.

 

It is the Company’s policy to prepare its financial statements on the accrual basis of accounting in conformity with GAAP. The interim condensed consolidated financial statements include the accounts of its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in the consolidation.

 

All dollar amounts included in the Notes to Condensed Consolidated Financial Statements are in thousands of U.S. dollars, except share and per share amounts.

 

In March 2020, the Company completed a 1-for-9 reverse stock split of the Company's issued and outstanding shares of common stock in order to regain compliance with Nasdaq's minimum bid price requirement. Accordingly, information in the financial statements and accompanying notes included in this Quarterly Report on Form 10-Q related to fiscal 2019 give effect to the reverse stock split as if it occurred at the beginning of the first period presented.

Reclassification

Previously reported amounts have been revised in the accompanying condensed consolidated statement of cash flows to properly state certain right to use assets and lease liabilities. These revisions had no impact on the company’s net cash provided by or used in operating activites.

Revenue Recognition

 

The Company recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects what it expects to receive in exchange for the goods or services.goods.

 

The Company’s principal activities from which it generates its revenue is product sales. The Company has one reportable segment of business.

 

Revenue is measured based on consideration specified in a contract with a customer. The Company recognizes revenue when it satisfies a performance obligation in a contract by transferring control over a product to a customer when product delivery occurs. Consideration is typically paid approximately 60 days from the time control is transferred. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from revenue. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as a fulfillment cost and are included in selling costs.

 

A performance obligation is a promise in a contract to transfer a distinct product to the customer, which for the Company is transfer of juvenile products to its customers. The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as the customer receives the benefit of the performance obligation.

 

A transaction price is the amount of consideration the Company expects to receive under the arrangement. The Company is required to estimate variable consideration (if any) and to factor that estimation into the determination of the transaction price. The Company conducts its business with customers through valid purchase or sales orders each of which is considered a separate contract because individual orders are not interdependent on one another. Product transaction prices on a purchase or sale order are discrete and stand-alone. Purchase or sales orders may be issued under either a customer master service agreement or a reseller allowance agreement. Purchase or sales orders, master service agreements, and reseller allowance agreements, which are specific and unique to each customer, may include product price discounts, markdown allowances, return allowances, and/or volume rebates which reduce the consideration due from customers. Variable consideration is estimated using the most likely amount method, which is based on historical experience as well as current information such as sales forecasts.

6

Contracts may also include cooperative advertising arrangements where the Company allows a discount from invoiced product amounts in exchange for customer purchased advertising that features the Company’s products. These allowances are generally based upon product purchases or specific advertising campaigns. Such allowances are accrued when the related revenue is recognized. These cooperative advertising arrangements provide a distinct benefit and fair value and are accounted for as direct selling expenses.

 

Use of Estimates

 

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect certain reported amounts of revenues, expenses, assets, liabilities and related disclosures. These estimates are based on management’s best knowledge as of the date the financial statements are published of current events and actions the Company may undertake in the future.  Accordingly, actual results could differ from those estimates.

 

Trade Receivables

 

Trade receivables are carried at their outstanding unpaid principal balances reduced by an allowance for doubtful accounts. The Company estimates doubtful accounts based on historical bad debts, factors related to specific customers’ ability to pay and current economic trends. The Company writes off accounts receivable against the allowance when a balance is determined to be uncollectible. Amounts are considered to be uncollectable based upon historical experience and management’s evaluation of outstanding accounts receivable.

 

Changes in the allowance for doubtful accounts are as follows:

 

 

For the
Nine months ended

 

 For the
three months ended
 

 

September
28, 2019

 

September
29, 2018

 

 March 28, 2020  March 30, 2019 

Allowance for doubtful accounts, beginning of period

 

$

304

 

$

1,622

 

 $542  $304 

Charges to costs and expenses, net

 

21

 

1,768

 

  23   9 

Account write-offs

 

 

(272

)

      

Allowance for doubtful accounts, end of period

 

$

325

 

$

3,118

 

 $565  $313 

 

Inventory Valuation

 

Inventory is comprised mostly of finished goods and some component parts and is stated at the lower of cost using the first-in, first-out (“FIFO”) method, or net realizable value. The Company regularly reviews slow-moving and excess inventories, and writes down inventories to net realizable value if the expected net proceeds from the disposals of excess inventory are less than the carrying cost of the merchandise.

 

Leases

 

The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets and operating lease liabilities in the Company’s condensed consolidated balance sheets.

 

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the Company’s leases do not provide an implicit rate, the Company’s uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.

 

The components of a lease should be split into three categories: lease components (e.g., land, building, etc.), non-lease components (e.g., common area maintenance, maintenance, consumables, etc.), and non-components (e.g., property taxes, insurance, etc.). Then the fixed and in-substance fixed contract consideration (including any related to non-components) must be allocated based on fair values to the lease components and non-lease components. Although separation of lease and non-lease components is required, certain practical expedients are available to entities. Entities electing the practical expedient would not separate lease and non-lease components. Rather, they would account for each lease component and the related non-lease component together as a single component. The Company’s facilities operating leases have lease and non-lease components to which the Company has elected to apply the practical expedient and account for each lease component and related non-lease component as one single component. The lease component results in a ROU asset being recorded on the balance sheet. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

7

Income Taxes

 

Income taxes are computed using the asset and liability method of accounting. Under the asset and liability method, a deferred income tax asset or liability is recognized for estimated future tax effects attributable to temporary differences and carry-forwards. The measurement of deferred income tax assets is adjusted by a valuation allowance, if necessary, to recognize future tax benefits only to the extent, based on available evidence, that it is more likely than not that such benefits will be realized. The net deferred tax assets and liabilities are presented as noncurrent.

 

The Company utilized the discrete method of accounting for income taxes in the U.S. for the three and nine months ended SeptemberMarch 28, 2020 and the three months ended March 30, 2019 as it believes the discrete method results in a more accurate representation of the income tax provisionbenefit for the period.quarter.

 

The Company follows the appropriate guidance relative to uncertain tax positions. This standard provides detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Uncertain tax positions must meet a recognition threshold of more-likely-than-not in order for those tax positions to be recognized in the financial statements.

 

On March 27, 2020, the U.S. CARES Act was enacted, which provided a substantial tax-and-spending package intended to provide additional economic stimulus to address the impact of the COVID-19 pandemic. The U.S. CARES Act provides numerous tax provisions and other stimulus measures, including temporary changes regarding the prior and future utilization of net operating losses, temporary changes to the prior and future limitations on interest deductions, temporary suspension of certain payment requirements for the employer portion of Social Security taxes, technical corrections from prior tax legislation for tax depreciation of certain qualified improvement property, and the creation of certain refundable employee retention credits. As a result of the U.S. CARES Act tax law changes, we recognized a $262 tax benefit related to the increase in interest deduction occurring during the fiscal year ended December 28, 2019 which was fully reserved for. The impact of the CARES Act in prospective periods may differ from our estimate as of March 28, 2020 due to changes in interpretations and assumptions, guidance that may be issued and actions the Company may take in response to the CARES Act. The CARES Act is highly detailed, and the Company will continue to assess the impact that various provisions will have on its business.

Net Loss/IncomeLoss Per Share

 

Basic loss per share for the Company is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted loss per share includes the dilutive impact of outstanding stock options and unvested restricted shares.

 

Translation of Foreign Currencies

 

All assets and liabilities of the Company’s foreign subsidiaries, each of whose functional currency is in its local currency, are translated into U.S. dollars at the exchange rate in effect at the end of the quarter and the income and expense accounts of these affiliates have been translated at average rates prevailing during each respective quarter. Resulting translation adjustments are made to a separate component of stockholders’ equity within accumulated other comprehensive loss. Foreign exchange transaction gains and losses are included in the accompanying interim, condensed consolidated statement of operations.

  

Recently Issued Accounting Pronouncements2020 Plan and COVID-19 Pandemic

The Company believes that its existing plan will generate sufficient cash which, along with its existing cash and availability under its facilities, will enable it to fund operations through at least the next 12 months. However, should the Company require additional cash, or should the impact from the COVID-19 pandemic discussed below be more severe than expected, the Company would identify other cost reductions or seek additional resources.

 

In February 2016,March 2020, the FASB issued ASU No. 2016-02, Leases (“ASU 2016-02”). ASU 2016-02 requires lesseesCOVID-19 outbreak was declared a global pandemic and became widespread in the U.S. While our products are considered “essential” and our distribution center located in California continues to recognize most leasesoperate, some of our customers have been impacted and, to the extent they operated retail stores, have been required to close their stores and curtail operations. We began to see an impact on their balance sheetorders at the end of March and may continue to see lower demand in the near term as a right-of-use assetgovernmental restrictions on businesses remain in place. Due to the uncertainty with respect to when governmental restrictions may be lifted and a lease liability. Leases are classified as either operating or finance, and classification is based on criteria similar to past lease accounting, but without explicit bright lines. In July 2018, the FASB issued ASU No. 2018-10, “Codification Improvements to Topic 842, Leases” (“ASU 2018-10”), which provides narrow amendments to clarify how to apply certain aspectswidespread nature of the new lease standard, and ASU No. 2018-11, “Leases (Topic 842) — Targeted Improvements” (ASU 2018-11), which addresses implementation issues related topandemic, we cannot currently predict how it will impact our business in the new lease standard. The guidance became effective for annual reporting periods beginning after December 15, 2018 and interim periods within those fiscal years.long term.

 

The Company adoptedis not currently aware of any events or circumstances arising from the standard onCOVID-19 pandemic that would require us to update any estimates, judgments or materially revise the effective datecarrying value of December 30, 2018 by applying the new lease requirements at the effective date. The Company also elected the package of practical expedients permitted under the transition guidance within the new standard, which, among other things, allows the Company to carry forward the historical lease classification. The impact of the adoption of ASC 842-Leases (“ASC 842”) on the condensed consolidated balance sheet on the date of adoption was an increase of $6,411 inour assets and an increase of $7,037 of liabilities for the recognition of right-of-use assets and leaseor liabilities. The adoption of ASC 842 was immaterial toCompany’s estimates may change, however, as events evolve and additional information is obtained, and any such changes will be recognized in the condensed consolidated results of operations and cash flows.

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

 

2.REVENUE

2.REVENUE

 

Disaggregation of Revenue

 

The Company’s revenue is primarily from distinct fixed-price product sales in the juvenile product market, to similar customers and channels utilizing similar types of contracts that are short term in nature (less than one year). The Company does not sell service agreements or goods over a period of time and does not sell or utilize customer financing arrangements or time-and-material contracts.

 

The following is a table that presents net sales by geographical area:

 

 For the
three months ended
 

 

For the three
months ended
September 28, 2019

 

For the three months
ended
September 29, 2018

 

 March 28, 2020  March 30, 2019 

United States

 

$

35,833

 

$

36,707

 

 $35,778  $36,236 

All Other

 

5,690

 

7,131

 

  4,560   6,302 

Net Sales

 

$

41,523

 

$

43,838

 

 $40,338  $42,538 

 

 

 

For the nine
months ended
September 28, 2019

 

For the nine months
ended
September 29, 2018

 

United States

 

$

111,133

 

$

111,210

 

All Other

 

19,353

 

22,361

 

Net Sales

 

$

130,486

 

$

133,571

 

All Other consists of Canada, Europe, South America, Mexico, Asia, and the Middle East.

 

Contract Balances

 

The Company does not have any contract assets such as work-in-process or contract liabilities such as customer advances. All trade receivables on the Company’s condensed consolidated balance sheetsheets are from contracts with customers.

 

Contract Costs

 

Costs incurred to obtain a contract are capitalized unless short term in nature. As a practical expedient, costs to obtain a contract that are short term in nature are expensed as incurred. All contract costs incurred in the ninethree months ended SeptemberMarch 28, 20192020 and ninethree months ended September 29, 2018March 30, 2019 fall under the provisions of the practical expedient and have therefore been expensed.

 

3.DEBT

8

3.DEBT

 

Credit Facilities

Bank of America Credit Facility. On June 28, 2018, the Company and Summer Infant (USA), Inc., as borrowers, entered into a Second Amended and Restated Loan and Security Agreement with Bank of America, N.A., as agent, the financial institutions party to the agreement from time to time as lenders, and certain subsidiaries of the Company as guarantors, as amended in January and March (as amended, the “Restated BofA Agreement”). The Restated BofA Agreement replaced the Company’s prior credit facility with Bank of America, and provides for a $60,000,an asset-based revolving credit facility with a $5,000 letter of credit sub-line facility. As of March 28, 2020, total revolver commitments under the credit facility were $48,000. The total borrowing capacity is based on a borrowing base, which is defined as 85% of eligible receivables plus the lesser of (i) 70% of the value of eligible inventory or (ii) 85% of the net orderly liquidation value of eligible inventory, less applicable reserves. The scheduled maturity date of loans under the Restated BofA Agreement is June 28, 2023 (subject to customary early termination provisions). On March 25, 2019,As a result of the Company and Summer Infant (USA), Inc., as borrowers, entered into Amendment No. 1amendments made to the Second Amended and Restated Loan and Security Agreement that modified the definitions of Capital Lease, EBITDA, Eligible Account and Revolver Borrowing Base in the Restated BofA Agreement in orderJanuary and March 2020, (i) the definition of Financial Covenant Trigger Amount was modified, (ii) the lenders' aggregate revolver commitments were reduced, (iii) the definition of EBITDA was amended to account for FASB mandated changes to lease accounting standardsexclude certain fees and provide additional financing flexibility to the Company. On November 1, 2019,expenses, (iv) the Company is required to meet certain minimum net sales amounts for each period of three consecutive fiscal months through the three-month period ending December 31, 2020, (v) the Company is required to meet a certain minimum EBITDA (as defined in the Restated BofA Agreement) as of the end of each fiscal month, calculated on a trailing 12-month period, (vi) the applicable margin and Summer Infant (USA), Inc., as borrowers, entered into Amendment No. 2 to the Second Amendedapplicable unused line fee rate were increased, and Restated Loan and Security Agreement.  See Note 8 for information regarding this amendment.(vii) certain reporting requirements were modified.

 

All obligations under the Restated BofA Agreement are secured by substantially all the assets of the Company, including a first priority lien on accounts receivable and inventory and a junior lien on certain assets subject to the term loanTerm Loan lender’s first priority lien described below. Summer Infant Canada Limited and Summer Infant Europe Limited, subsidiaries of the Company, are guarantors under the Restated BofA Agreement. Proceeds from the loans were used to satisfy existing debt, pay fees and transaction expenses associated with the closing of the Restated BofA Agreement and may be used to pay obligations under the Restated BofA Agreement, and for lawful corporate purposes, including working capital.

 

Loans under the Restated BofA Agreement bear interest, at the Company’s option, at a base rate or at LIBOR, plus applicable margins based on average quarterly availability under the Restated BofA Agreement. Interest payments are due monthly, payable in arrears. The Company is also required to pay an annual non-use fee on unused amounts, as well as other customary fees as are set forth in the Restated BofA Agreement. The Restated BofA Agreement contains customary affirmative and negative covenants. Among other restrictions, the Company is restricted in its ability to incur additional debt, make acquisitions or investments, dispose of assets, or make distributions unless in each case certain conditions are satisfied. The Company is also required to meet certain financial covenants through the end of fiscal 2020, specifically (a) a minimum net sales amount for each period of three consecutive fiscal months, measured at the end of each month, and (b) a trailing, 12-month minimum adjusted EBITDA amount (as defined in the Restated BofA Agreement), measured at the end of each fiscal month. In addition, if availability falls below a specified amount,the following amounts, a springing covenant would be in effect requiring the Company to maintain a fixed charge coverage ratio at the end of each fiscal month of at least 1.0 to 1.0 for the twelve-month period then ended.ended: (i) $3,000 through May 31, 2020, (ii) $3,500 from June 1 through June 30, 2020, (iii) $3,750 from July 1 through August 31, 2020, (iv) $4,000 from September 1 through September 30, 2020, (v) $4,250 from October 1 through October 31, 2020, (vi) $4,500 from November 1 through November 30, 2020, and (vii) $5,000 at any time from and after December 1, 2020.

 

The Restated BofA Agreement also contains customary events of default, including a cross default with the Term Loan Agreement or the occurrence of a change of control. In the event of a default, the lenders may declare all of the obligations of the Company and its subsidiaries under the Restated BofA Agreement immediately due and payable. For events of default relating to insolvency and receivership, all outstanding obligations automatically become due and payable without any action on the part of the lenders.

 

As of SeptemberMarch 28, 2019,2020, under the Restated BofA Agreement, the rate on base-rate loans was 6.25%5.0% and the rate on LIBOR-rate loans was 4.375%3.5%. The amount outstanding on the Restated BofA Agreement at SeptemberMarch 28, 2019,2020, was $32,000. Total borrowing capacity at September 28, 2019 was $38,852$28,063 and borrowing availability was $6,852.$5,626.

 

PriorThe amendments executed in the three months ended March 28, 2020 were evaluated, to enteringdetermine the proper accounting treatment for the transactions. Accordingly, debt extinguishment accounting was used to account for the reduction in the total revolver commitments under the credit facility, resulting in the write off of $266 in remaining unamortized deferred financing costs during the three months ended March 28, 2020.

Subsequent to fiscal quarter end, on April 29, the Company entered into further amendments to the Restated BofA Agreement, the Company and Summer Infant (USA), Inc. were parties to an amended and restated loan and security agreement with Bank of America, N.A., as agent, which providedAgreement. See Note 8 for an asset-based credit facility (the “Prior Credit Facility”). The Prior Credit Facility consisted of a $60,000 asset-based revolving credit facility, with a $10,000 letter of credit sub-line facility (the “Revolving Facility”), a $5,000 “first in last out” revolving credit facility (the “FILO

Facility”) and a $10,000 term loan facility (the “Term Loan Facility”). The total borrowing capacity under the Revolving Facility was based on a borrowing base, generally defined as 85% of the value of eligible accounts plus the lesser of (i) 70% of the value of eligible inventory or (ii) 85% of the net orderly liquidation value of eligible inventory, less reserves. The total borrowing capacity under the FILO Facility was based on a borrowing base, generally defined as a specified percentage of the value of eligible accounts that steps down over time, plus a specified percentage of the value of eligible inventory that stepped down over time. As noted above, all obligations under the Revolving Facility and Term Loan Facility were repaid in connection with the Restated BofA Agreement and Term Loan Agreement described below. Loans under the FILO Facility were repaid on April 21, 2018.information regarding these amendments.

 

Term Loan Agreement. On June 28, 2018, the Company and Summer Infant (USA), Inc., as borrowers, entered into a Term Loan and Security Agreement (as amended, the “Term Loan Agreement”) with Pathlight Capital LLC, as agent, each lender from time to time a party to the Term Loan Agreement,thereto , and certain subsidiaries of the Company as guarantors, as amended in January and March 2020 (as amended, the “Term Loan Agreement”) providing for a $17,500 term loan (the “Term Loan”). Proceeds from the Term Loan were used to satisfy existing debt, pay fees and transaction expenses associated with the closing of the Term Loan and may be used to pay obligations under the Term Loan Agreement, and for lawful corporate purposes, including working capital. The Term Loan is secured by a lien on certain assets of the Company, including a first priority lien on intellectual property, machinery and equipment, and a pledge of (i) 100% of the ownership interests of domestic subsidiaries and (ii) 65% of the ownership interests in certain foreign subsidiaries of the Company, and a junior lien on certain assets subject to the liens under the Restated BofA Agreement described above. The Term Loan matures on June 28, 2023. Summer Infant Canada Limited and Summer Infant Europe Limited, subsidiaries of the Company, are guarantors under the Term Loan Agreement. On March 25, 2019,As a result of the Company and Summer Infant (USA), Inc., as borrowers, entered into Amendment No. 1amendments made to the Term Loan Agreement in January and Security Agreement thatMarch 2020, (i) the definitionof IP Advance Rate Reduction was modified, (ii) the definition of Term Loan Borrowing Base was modified to deduct a specified equipment reserve amount from the calculation of the borrowing base, (iii)the definitions of Financial Covenant trigger and EBITDA were amended consistent with the amendment of the Restated BofA Agreement, and also modified(iv) consistent with the IP Advance Rate Reduction Amount definition in order to provide additional financing flexibility to the Company. On November 1, 2019,Restated BofA Agrement, the Company is required to meet certain minimum net sales amounts for each period of three consecutive fiscal months through the three-month period ending December 31, 2020; and Summer Infant (USA), Inc.,certain minimum EBITDA as borrowers, entered into Amendment No. 2of the end of each fiscal month, calculated on a trailing 12-month period, (v) principal payments on the term loan were suspended for 2020, such payments to resume in March 2021, and (vi) certain reporting requirements were modified. In addition, as described below, beginning March 10, 2020, the Term Loan and Security Agreement.  See Note 8 for information regarding this amendment.term loan began to bear additional interest, to be paid in kind ("PIK interest") at annual rate of 4.0%.

9

 

The principal of the Term Loan is being repaid, on a quarterly basis, in installments of $219, with the first installment having been paid on December 1, 2018, until paid in full on termination. In connection with the March 2020 amendment, principal payments on the Term Loan were suspended for 2020, to resume in March 2021. The Term Loan bears interest at an annual rate equal to LIBOR, plus 9.0%. Interest payments are due monthly, in arrears. In addition, the Term Loan began to accrue PIK (payment in kind) interest at an annual rate of 4.0% in March 2020, which interest will become payable upon the earlier to occur of (i) the repayment of the Term Loan in full, (ii) a sale or merger of the Company, (iii) the occurrence of default or event of default under the Term Loan Agreement, or (iv) the Company achieving adjusted EBITDA of $12 million (calculated on a trailing, 12-month basis). If, and only if, the PIK interest becomes due and payable as a result of the Company achieving the adjusted EBITDA event noted in clause (iv), then the Company will pay all PIK interest then due and thereafter, PIK interest will continue to accrue and be paid on each subsequent anniversary of such event. Obligations under the Term Loan Agreement are also subject to restrictions on prepayment and a prepayment penalty if the Term Loan is repaid prior to the third anniversary of the closing of the Term Loan.

 

The Term Loan Agreement contains customary affirmative and negative covenants that are substantially the same as the Restated BofA Agreement. Consistent with the Restated BofA Agreement, the Company is also required to meet certain financial covenants through the end of fiscal 2020, specifically (a) a minimum net sales amount for each period of three consecutive fiscal months, measured at the end of each month, and (b) a trailing, 12-month minimum adjusted EBITDA amount (as defined in the Restated BofA Agreement), measured at the end of each fiscal month. In addition, consistent with the Restated BofA Agreement, if availability falls below a specified amount as described above, then the Company must maintain a fixed charge coverage ratio at the end of each fiscal month of at least 1.0 to 1.0 for the twelve-month period then ended. The Term Loan Agreement also contains events of default, including a cross default with the Restated BofA Agreement or the occurrence of a change of control. In the event of a default, the lenders may declare all of the obligations of the Company and its subsidiaries under the Term Loan Agreement immediately due and payable. For events of default relating to insolvency and receivership, all outstanding obligations automatically become due and payable without any action on the part of the lenders.

 

As of SeptemberMarch 28, 2019,2020, the interest rate on the Term Loan was 11.13%.10.6% of cash interest and 4.0% of PIK interest. The amount outstanding on the Term Loan at SeptemberMarch 28, 20192020 was $16,625.$16,406.

 

Aggregate maturities of bank debt related to the Restated BofA Agreement and the Term Loan Agreement:Agreement are as follows:

 

Fiscal Year ending:

 

 

 

   

2019

 

219

 

2020

 

875

 

  0 

2021

 

875

 

  875 

2022

 

875

 

  875 

2023 and thereafter

 

$

45,781

 

2023  42,719 

Total

 

$

48,625

 

 $44,469 

 

Unamortized debt issuance costs were $2,282$2,491 at SeptemberMarch 28, 20192020 and $2,395$2,398 at December 29, 2018,28, 2019, and are presented as a direct deduction of long-term debt on the consolidated balance sheets.

 

4.INTANGIBLE ASSETSSubsequent to fiscal quarter end, on April 29, the Company entered into further amendments to the Term Loan Agreement. See Note 8 for information regarding these amendments.

Due to the uncertainty with respect to the duration of the COVID-19 pandemic and its impact on the U.S. economy in the short and long term, it is possible that demand for our products may decrease and, as a result, we may be unable to meet the financial covenants under the Restated BofA Agreement and Term Loan Agreement. In such a case, the Company would seek to mitigate such an impact through cost reductions, restructuring its existing indebtedness, or amending or seeking relief from these covenants from its lenders.

4.INTANGIBLE ASSETS

 

Intangible assets consisted of the following:

 

 

 

September 28,
2019

 

December 29,
2018

 

 

 

 

 

 

 

Brand names

 

$

11,819

 

$

11,819

 

Patents and licenses

 

4,047

 

3,766

 

Customer relationships

 

6,946

 

6,946

 

Other intangibles

 

1,882

 

1,882

 

 

 

24,694

 

24,413

 

Less: Accumulated amortization

 

(11,667

)

(11,113

)

Intangible assets, net

 

$

13,027

 

$

13,300

 

  March 28,  December 28, 
  2020  2019 
Brand names $11,819  $11,819 
Patents and licenses  4,126   4,101 
Customer relationships  6,946   6,946 
Other intangibles  1,882   1,882 
   24,773   24,748 
Less: Accumulated amortization  (11,974)  (11,852)
Intangible assets, net $12,799  $12,896 

10

The amortization period for the majority of the intangible assets ranges from 5 to 20 years for those assets that have an estimated life; certain of the assets have indefinite lives (brand names). Total of intangibles not subject to amortization amounted to $8,400 as of SeptemberMarch 28, 20192020 and December 29, 2018.28, 2019.

 

5.COMMITMENTS AND CONTINGENCIES

5.COMMITMENTS AND CONTINGENCIES

 

Leases

 

The Company leases office space and distribution centers primarily related to its Riverside California, Canada, United Kingdom, and Hong Kong operations. In connection with these leases, there were no cash incentives from the landlord to be used for the construction of leasehold improvements within the facility. Our headquarters in Woonsocket, Rhode Island continues to be accounted for as a sale-leaseback lease. Beginning in April 2020, the Company subleased a portion of its Riverside warehouse lease. The sub-lease has an initial term of one year, with an option to extend on a month to month basis for the remainder of the head lease. The Company will record the sublease income net of lease expense.

 

The Company identified and assessed the following significant assumptions in recognizing the right-of-use asset and corresponding liabilities:

 

·Expected lease term — The expected lease term includes both contractual lease periods and, when applicable, cancelable option periods when it is reasonably certain that the Company would exercise such options. These leases have remaining lease terms between 1 month and 3.75 years. The Canada lease has one 5-year extension option that has also not been included in the lease term.

·Expected lease term —The expected lease term includes both contractual lease periods and, when applicable, cancelable option periods when it is reasonably certain that the Company would exercise such options. As of March 28, 2020, these leases had remaining lease terms between 1.5 and 3.3 years. The Canada lease has one 5-year extension option that has also not been included in the lease term.

 

·Incremental borrowing rate — The Company’s lease agreements do not provide an implicit rate. As the Company does not have any external borrowings for comparable terms of its leases, the Company estimated the incremental borrowing rate based on secured borrowings available to the Company for the next 5 years. This is the rate the Company would have to pay if borrowing on a collateralized basis over a similar term in an amount equal to the lease payments in a similar economic environment.

·Incremental borrowing rate — The Company’s lease agreements do not provide an implicit rate. As the Company does not have any external borrowings for comparable terms of its leases, the Company estimated the incremental borrowing rate based on secured borrowings available to the Company for the next 5 years. This is the rate the Company would have to pay if borrowing on a collateralized basis over a similar term in an amount equal to the lease payments in a similar economic environment.

 

·Lease and non-lease components — In certain cases the Company is required to pay for certain additional charges for operating costs, including insurance, maintenance, taxes, and other costs incurred, which are billed based on both usage and as a percentage of the Company’s share of total square footage. The Company determined that these costs are non-lease components and they are not included in the calculation of the lease liabilities because they are variable. Payments for these variable, non-lease components are considered variable lease costs and are recognized in the period in which the costs are incurred.

·Lease and non-lease components —In certain cases the Company is required to pay for certain additional charges for operating costs, including insurance, maintenance, taxes, and other costs incurred, which are billed based on both usage and as a percentage of the Company’s share of total square footage. The Company determined that these costs are non-lease components and they are not included in the calculation of the lease liabilities because they are variable. Payments for these variable, non-lease components are considered variable lease costs and are recognized in the period in which the costs are incurred.

 

The components of the Company’s lease expense for the three and nine months ended SeptemberMarch 28, 2020 and March 30, 2019 were as follows:

 

 

For the

three months ended

 

 

Three Months Ended
September 28, 2019

 

Nine Months Ended
September 28, 2019

 

 March 28, 2020  March 30, 2019 

Operating lease cost

 

$

622

 

$

1,867

 

 $621  $623 

Variable lease cost

 

262

 

890

 

  267   362 

Total lease expense

 

$

884

 

$

2,757

 

Total lease cost $888  $985 

 

Weighted-average remaining lease term

2.341.85 years

Weighted-averageWeighted Average discount rate:

5.00%

 

Cash paid for amounts included in the measurement of the Company’s lease liabilities were $1,946$662 and $648 for the ninethree months ended SeptemberMarch 28, 2019.2020 and March 30, 2019 respectively.

 

As of SeptemberMarch 28, 2019,2020, the present value of maturities of the Company’s operating lease liabilities were as follows:

 

Fiscal Year Ending:

 

 

 

2019

 

$

643

 

2020

 

2,545

 

2021

 

2,036

 

2022

 

316

 

2023

 

151

 

Less imputed interest

 

(333

)

Total

 

$

5,358

 

Fiscal Year Ending:   
2020 $2,005 
2021  2,136 
2022  299 
2024  143 
2024  0 
Less imputed interest  (216)
Total $4,367 

Prior

Subsequent to fiscal quarter end, on April 24, 2020, the Company entered into an amendment to the adoption of ASU 2016-02 andlease for the nine months ended September 29, 2018, the Company recognized rent expense on a straight-line basis over the lease period and recorded deferred rent expenseits Woonsocket headquarters. See Note 8 for rent expense incurred but not yet paid. The Company also recorded deferred rent attributable to cash incentives received under its lease agreements which are amortized to rent expense over the lease term. During the three and nine months ended September 29, 2018, the Company recognized rent expense of $614 and $1,842 respectively.information regarding this amendment.

 

Disclosures related to periods prior to adoption of the new lease standard:

11

 

Under ASC 840 “Leases”, approximate future minimum rental payments due under these leases as of December 29, 2018 were as follows:

Fiscal Year Ending:

 

 

 

2019

 

$

2,627

 

2020

 

2,556

 

2021

 

2,048

 

2022

 

323

 

2023 and beyond

 

154

 

Total (a)

 

$

7,708

 


(a)         Amounts exclude payments for sales-leaseback transaction of the Woonsocket headquarters.

 

Litigation

 

The Company is a party to various routine claims, litigation and administrative complaints incidental to its business, including claims involving product liability, employee matters and other general liability claims, most of which are covered by insurance. We are not aware of any such proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, results of operations or financial condition.

 

6.SHARE BASED COMPENSATION

6.SHARE BASED COMPENSATION

 

The Company is currently authorized to issue up to 1,700,000 shares for equity awards under the Company’s 2012 Incentive Compensation Plan (as amended, “2012 Plan”). Periodically, the Company may also grant equity awards outside of its 2012 Plan as inducement grants for new hires.

 

Under the 2012 Plan, awards may be granted to participants in the form of non-qualified stock options, incentive stock options, restricted stock, deferred stock, restricted stock units and other stock-based awards. Subject to the provisions of the plans, awards may be granted to employees, officers, directors, advisors and consultants who are deemed to have rendered or are able to render significant services to the Company or its subsidiaries and who are deemed to have contributed or to have the potential to contribute to the Company’s success. The Company accounts for options under the fair value recognition standard. Share-based compensation expense, net of forfeitures, for the ninethree months ended SeptemberMarch 28, 2020 and March 30, 2019 was a credit of $11 and September 29, 2018 was $224 and $433,expense of $48, respectively. Share based compensation expense is included in general and administrative expenses.

 

The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the table below. The Company uses the simplified method to estimate the expected term of the options, but used an estimate for grants of “plain vanilla” stock options based on a formula prescribed by the Securities and Exchange Commission. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Share-based compensation expense recognized in the consolidated financial statements is based on awards that are ultimately expected to vest.

 

As of SeptemberMarch 28, 2019,2020, there were 1,010,62365,619 stock options outstanding and 280,27513,669 unvested restricted shares outstanding.

 

During the ninethree months ended SeptemberMarch 28, 2019,2020, the Company granted 244,000did not grant stock options and 172,500or shares of restricted stock, respectively.stock. The following table summarizes the weighted average assumptions used for stock options granted during the ninethree months ended September 28, 2019 and September 29, 2018.March 30, 2019.

 

 

For the Nine
Months Ended
September 28, 2019

 

For the Nine
Months Ended
September 29, 2018

 

Expected life (in years)

 

5.0

 

4.9

 

Risk-free interest rate

 

2.3

%

2.7

%

Volatility

 

64.2

%

64.0

%

Dividend yield

 

0

%

0

%

Forfeiture rate

 

24.2

%

23.1

%

For the Three
Months Ended
March 30, 2019
Expected life (in years)4.8
Risk-free interest rate2.5%
Volatility66.9%
Dividend yield0%
Forfeiture rate23.8%

 

As of SeptemberMarch 28, 2019,2020, there were 558,20893,244 shares available to grant under the 2012 Plan.

 

7.WEIGHTED AVERAGE COMMON SHARES

7.WEIGHTED AVERAGE COMMON SHARES

 

Basic and diluted earnings or loss per share (“EPS”) is based upon the weighted average number of common shares outstanding during the period. Diluted weighted average number of common shares outstanding also included common stock equivalents such as stock options and restricted shares, using the treasury stock method.shares. The Company does not include the anti-dilutive effect of common stock equivalents in the calculation of dilutive common shares outstanding. The computation of diluted common shares for the three months ended SeptemberMarch 28, 2019 2020 excluded the effect of 1,010,62365,619 stock options and 280,275 shares of restricted stock outstanding because the effects would be anti-dilutive due to the Company’s net loss and the three months ended September 29, 2018 excluded the effect of 1,117,327 stock options and 312,47113,669 shares of restricted stock outstanding. The computation of diluted common shares for the ninethree months ended September 28,March 30, 2019 excluded the effect of 1,010,623115,179 stock options and 280,27522,856 shares of restricted stock outstanding and the nine months ended September 29, 2018 excluded the effect of 1,183,510 stock options and 335,775 shares of restricted stock outstanding because the effects would be anti-dilutive due to the Company’s net loss for both periods.outstanding.

 

8.SUBSEQUENT EVENTS

12

8.SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events through the filing date of this Quarterly Report on Form 10-Q and determined that no subsequent events occurred that would require recognition in the consolidated financial statements or disclosure in the notes thereto except as set forth herein.follows:

 

Following the end of the period covered by this report,Amendments to Restated BofA Agreement

On April 29, 2020, the Company and Summer Infant (USA), Inc., as borrowers and certain subsidiaries of the Company as guarantors, entered into amendmentsAmendment No. 5 to eachthe Restated BofA Agreement. The amendment modified the terms of the Restated BofA Agreement to (a) increase the applicable margins; (b) add a LIBOR floor of 0.75% and (c) with respect to the financial covenants (i) for the months ending April through August 2020, adjusted the minimum net sales amounts the Company must meet for each period of three consecutive fiscal months, and (ii) for the months ending April through December 2020, adjusted the minimum EBITDA (as defined in the Restated BofA Agreement) the Company must meet as of the end of each fiscal month, calculated on a trailing 12-month period.

Amendments to Term Loan Agreement as described below.  Please see Note 3 for additional information regarding the Restated BofA Agreement and the Term Loan Agreement.

 

Amendment to Restated BofA AgreementOn November 1, 2019,April 29, 2020, the Company and Summer Infant (USA), Inc., as borrowers, and certain subsidiaries of the Company as guarantors, entered into a letter agreement amending Amendment No. 24 to the Restated BofA Agreement (the “BofA Amendment”).Term Loan Agreement. The BofA Amendment amendedletter agreement modified the terms of the Restated BofA Agreement to, among other things, (a) increase the applicable margins on base rate and LIBOR revolver loans by 50 basis points, (b) modify the definition of Financial Covenant Trigger Amount so that the amount is (i) $4,000,000 through January 15, 2020, (ii) from January 16, 2020 through March 31, 2020, the amount will be (A) $4,000,000 or (B) $5,000,000 if the Company is not in compliance with certain covenants, and (iii) from and after April 1, 2020, $5,000,000; and (c) require that the Company engage a financial advisor to assist with providing a weekly, 13-week cash flow forecast.

Amendment to Term Loan Agreement.  On November 1, 2019, the Company and Summer Infant (USA), Inc., as borrowers, entered into Amendment No. 24 to the Term Loan Agreement (the “Term Loan Amendment”).  The Term Loanto (a) add a LIBOR floor of 0.75% and (b) modify the financial covenants consistent with Amendment amendedNo. 5 to the termsBofA Amendment.

Amendment to Lease

On April 24, 2020, Summer Infant (USA), Inc. (“Summer USA”), a wholly-owned subsidiary of the Term Loan AgreementCompany, entered into the Third Amendment to Lease (the “Amendment”) with Faith Realty II, LLC (the “Landlord”) dated March 24, 2009. The Landlord is a company owned by Jason Macari, a former officer and director of the Company and a holder of more than ten percent of the Company’s outstanding common stock. The Amendment modified the lease to, among other things, (a) amend(i) extend the definitioncurrent term of Financial Covenant Trigger Amountthe lease to be consistent withJune 2025, (ii) reduce the BofA Amendment, (b) amendpremises occupied by Summer USA under the definitionlease, (iii) reduce the annual base rent payments for the term of IP Advance Rate Reductionthe lease and (iv) provide Summer USA two options to provide thatextend the amountterm of reduction will be (i) zero through December 31, 2019, (ii) 5.0 percentage points from Januarythe lease for an additional period of five-year terms upon prior written notice.

Sublease of Warehouse Space

Effective April 1, 2020, through March 30, 2020, provided the Company complies with certain covenants,subleased a portion of its warehouse located in Riverside, California. The initial term of the sublease is one year, and (iii) 10.0 percentage pointsthereafter shall continue on and after March 31, 2020; and (c) consistent witha month-to-month basis until the BofA Amendment, require thattermination of the master lease or, if earlier, if terminated upon 30 days’ prior written notice of the Company engage a financial advisor to assist with providing a weekly, 13-week cash flow forecast.or the sublessor. The Company will receive base rent of $83 per month for the initial term of the sublease.

13

ITEM 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

ITEM 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The statements contained in this Quarterly Report on Form 10-Q that are not purely historical are forward-looking information and statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All forward-looking statements included in this document are based on information available to us on the date hereof. It is important to note that our actual results could differ materially from those projected in such forward-looking statements contained in this Quarterly Report on Form 10-Q. These forward-looking statements include statements concerning our expectations regardingthe impact of existing tariffs or new tariffsthe COVID-19 pandemic on our financial condition and results of operations in the cost ofnear and long term; anticipated savings from our imported productsongoing restructuring efforts; and pricing of our products, as well as the expected effect of our mitigation efforts; our business strategy and future growth and profitability; our ability to deliver high quality, innovative products to the marketplace; our ability to maintain and build upon our existing customer and supplier relationships; our expected cash flow and liquidity for the next 12 months; our ability to obtain additional capital for our business or identify potential strategic transactions; and our ability to build awareness of our core brands.months. These statements are based on current expectations that involve numerous risks and uncertainties.  These risks and uncertainties include the impact of the COVID-19 outbreak on our business operations, and the U.S. and global economies; the concentration of our business with retail customers; potential liquidity problems or bankruptcy of our customers and their ability to pay us in a timely manner; our ability to comply with financial and other covenants in our debt agreements; our ability to work with our lenders to amend our existing debt agreements, if required; our ability to raise additional funds or engage in a strategic transaction, if necessary; our ability to introduce new products or improve existing products that satisfy consumer preferences; our ability to develop new or improved products in a timely and cost-efficient manner; our ability to meet the continued listing requirements for the listing of our common stock on the Nasdaq Capital Market; liquidity problems or bankruptcy of our customers and their ability to pay us in a timely manner; our ability to compete with larger and more financially stable companies in our markets; our dependence on key personnel; our reliance on foreign suppliers and potential disruption in foreign markets in which we operate; potential increases in the cost of products or the cost raw materials used to manufacture our products; changes in international trade policy and the imposition of tariffs or other fees by the United States or other countries on our products; compliance with safety and testing regulations for our products; potential product liability claims arising from use of our products; unanticipated tax liabilities; ana potential impairment of other intangible assets; and other risks as detailed in our Annual Report on Form 10-K for the year ended December 29, 2018,28, 2019, as amended, this Quarterly Report on Form 10-Q and subsequent filings with the Securities and Exchange Commission. All these matters are difficult or impossible to predict accurately, many of which may be beyond our control. Although we believe that the assumptions underlying our forward-looking statements are reasonable, any of the assumptions could be inaccurate and, therefore, there can be no assurance that the forward-looking statements included in this Quarterly Report on Form 10-Q will prove to be accurate.

 

The following discussion is intended to assist in the assessment of significant changes and trends related to the results of operations and financial condition of our Company and our consolidated subsidiaries.  This Management’s Discussion and Analysis should be read together with the unaudited interim condensed consolidated financial statements and related notes included elsewhere in this filing and with our consolidated financial statements for the year ended December 29, 201828, 2019 included in our Annual Report on Form 10-K for the year ended December 29, 2018,28, 2019, as amended (“20182019 Form 10-K”).

 

Note that all dollar amounts in this section are in thousands of U.S. dollars, except share and per share data.

 

Overview

 

We are an infant and juvenile products company originally founded in 1985 and have publicly traded on the Nasdaq Stock Market since 2007 under the symbol “SUMR.” We are a recognized authority in the juvenile industry, providing parents and caregivers a full range of innovative, high-quality, and high-value products to care for babies and toddlers. We seek to improve the quality of life of parents, caregivers, and babies through our product offerings, while at the same time maximizing shareholder value over the long term.offerings.

 

We operate in one principal industry segment across geographically diverse marketplaces, selling our products globallyprimarily in North America to large, national retailers as well as independent retailers, and on our partner’s websites and our own direct to consumerdirect-to-consumer websites. In North America, our customers include Amazon.com, Wal-Mart, Target, Buy Buy Baby, Home Depot, and Lowe’s. Our largest European-based customers are Argos and Amazon. We also sell through international distributors, representatives, and to select international retail customers in geographic locations where we do not have a direct sales presence.

 

In the thirdfirst quarter of 2019,2020, sales declined 5.3%5.2% as compared to the prior year period. period, principally as a result ofWhile sales to our top customers remained strong during the quarter, higher retail price points in response to tariffs imposed on goods imported from China softened demand and resulted in a decline in sales. Our mid-tier and international customers  were also affected by fewer channels and a strong dollar. Gross profit dollars decreased by 7.5% as comparedreacting to the same prior year period principallyearly stages of the COVID-19 pandemic in March. Gross margin declined by 60 basis points due to higher closeout sales in part due to the declineliquidation of inventory associated with the closure of our UK warehouse in sales levels combined with higher tariffs while selling expenses decreased 1.7% as a result of lower sales.March. General and administrative expenses increased 9.6%declined 13.1% as compared to the prior period largely dueas the Company began to $284 in legal settlement chargesimplement restructuring actions in the thirdfirst quarter while the prior year quarter includedof 2020, including a credit of $535 to decrease a bad debt allowance for a partial recovery from the TRU bankruptcy.reduction in work force and other cost reductions partially offset by severance costs. Net loss per diluted share for the quarter was $0.09declined to $0.57 per share as compared to a net incomeloss of $0.01$0.67 per share for the comparable prior period.

 

During the third quarter, tariffswe successfully completed a 1-for-9 reverse stock split of our Company's issued and outstanding shares of common stock in order to regain compliance with Nasdaq's minimum bid price requirement. Accordingly, information in the financial statements and accompanying notes included in this Quarterly Report on Form 10-Q related to fiscal 2019 give effect to the reverse stock split as if it occurred at the first period presented.

14

Restructuring Initiatives. In early 2020 and prior to the COVID-19 outbreak in the U.S., we announced restructuring initiatives to further streamline operations and improve our financial outlook. We anticipate that, if these initial initiatives are fully implemented, these actions will result in annualized cost savings of approximately $7,500 when complete. As of the end of April 2020, we have taken many of these actions, including headcount reductions, reductions in facility space, and other cost reductions, and believe we are on track to realize the expected $7,500 in annualized cost savings. At the end of March, we vacated our distribution center located in the U.K. To further reduce expenses, in April 2020, we completed a sublease of a portion of our California distribution center and an amendment to our lease of our headquarters located in Rhode Island that reduced the size of premises occupied by us and correspondingly will reduce our base rent going forward. During the quarter and in April 2020, we also worked with our lenders to amend our credit facility and term loan agreement to permit us the ability to undertake various restructuring initiatives and to provide additional liquidity, as well as to address the potential short-term impact of the COVID-19 pandemic.

Impact of the COVID-19 Pandemic. As discussed in our 2019 Form 10-K, we experienced some delays in manufacturing and shipment of our products to the U.S., as the majority of our products are sourced from China. Sales in the first quarter were consistent with our forecast until March, when the COVID-19 pandemic spread to the U.S. Because our products are considered “essential” and our distribution center is located in California, we have continued to impactship products without interruption.

In March, we began to see customers that have retail stores reduce orders as they experienced or anticipated closures of those stores. While we did see an uptick in sales to those customers with significant e-commerce capabilities, it did not offset the reduced orders from our resultsour mid-size and smaller customers.

We have seen manufacturing and shipments from China return to more normal levels, however suppliers that are located in other areas, including Mexico, are now subject to closure as a consequenceresult of the COVID-19 pandemic. As a result, the potential exists that we faced some liquidity constraints.   Based onmight not be able to meet demand for certain products that are manufactured by suppliers that are subject to closure, and we are looking to potential other suppliers for those products.

We expect that our current projections, we believe wesales in the second quarter of 2020 will continue to facebe impacted by the COVID-19 pandemic as some liquidity constraintsretail stores remain closed. We believe that customers with e-commerce capabilities will continue to have high demand and we hope that, as stores begin to reopen across the U.S., we will see a corresponding increase in orders from customers with retail stores. However, given the unpredictability of the COVID-19 pandemic, it is possible that stores will remain closed, or that outbreaks may reoccur later in the near term.  As discussed belowyear. With our mid-size and smaller customers, we have begun to see some of these customers ask for extensions in Liquiditypayment terms. We expect these customers may experience financial difficulties, and Capital Resources,we are taking steps to limit risk of non-payment from these customers.

While reduced sales in the second quarter will have an impact on November 1, 2019,our operating cash flow, as noted above, we amendedhave been working with our loan agreementslenders to provide additional flexibility as we ramp up for fiscal 2020, and expect that the steps we have taken to mitigatemaintain liquidity during this uncertain time. We will continue to monitor the impact of tariffs start to take effect. To the extent we are unable to

offset the impact of  tariffsCOVID-19 pandemic on our net sales or are unablecustomers, and the U.S. economy in general, however, due to raise additional capital or engage in a strategic transaction,the uncertainty with respect to when stay-at-home and similar restrictions may be lifted and the widespread nature of the COVID-19 pandemic, we cannot currently predict how it will impact our business financial position, resultsin the latter half of operations and cash flows would be adversely affected.2020.

Summary of Critical Accounting Policies and Estimates

 

There have been no significant changes in our critical accounting policies and estimates during the ninethree months ended SeptemberMarch 28, 20192020 from our critical accounting policies and estimates disclosed under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 20182019 Form 10-K except for the adoption of the new lease accounting rules in the first quarter of fiscal 2019 as noted in Note 1 to our condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.10-K.

 

Results of Operations

 

 

 

For the three months ended
(Unaudited)

 

For the nine months ended
(Unaudited)

 

 

 

September 28, 2019

 

September 29, 2018

 

September 28, 2019

 

September 29, 2018

 

Net sales

 

$

41,523

 

$

43,838

 

$

130,486

 

$

133,571

 

Cost of goods sold

 

28,928

 

30,227

 

89,599

 

90,974

 

Gross profit

 

12,595

 

13,611

 

40,887

 

42,597

 

General & administrative expenses

 

8,353

 

7,623

 

26,255

 

29,587

 

Selling expenses

 

3,597

 

3,658

 

10,981

 

9,427

 

Depreciation and amortization

 

919

 

1,012

 

2,808

 

3,087

 

Operating income (loss)

 

(274

)

1,318

 

843

 

496

 

Interest expense, net

 

1,191

 

1,118

 

3,733

 

3,300

 

Income (loss) before provision (benefit) for income taxes

 

(1,465

)

200

 

(2,890

)

(2,804

)

Provision (benefit) for income taxes

 

195

 

82

 

392

 

(513

)

Net income (loss)

 

$

(1,660

)

$

118

 

$

(3,282

)

$

(2,291

)

  For the Three Months Ended 
  (Unaudited) 
  March 28, 2020  March 30, 2019 
Net sales $40,338  $42,538 
Cost of goods sold  27,835   29,088 
Gross profit  12,503   13,450 
General and administrative expense  8,147   9,379 
Selling expense  3,444   3,353 
Depreciation and amortization  967   937 
Operating loss  (55)  (219)
Interest expense, net  1,410   1,249 
Loss before income taxes  (1,465)  (1,468)
Benefit for income taxes  (255)  (70)
Net loss $(1,210) $(1,398)

15

 

Three Months ended SeptemberMarch 28, 20192020 compared with Three Months ended September 29, 2018March 30, 2019

 

Net sales decreased 5.3%5.2% from $43,838$42,538 for the three months ended September 29, 2018March 30, 2019 to $41,523$40,338 for the three months ended SeptemberMarch 28, 2019. Sales to our top customers remained strong and we increased sales across several2020. The decrease was primarily a result of our product categories, includingthe early stages of the economic effect from the COVID-19 pandemic partially offset by an increase of sale of specialty blankets, strollers, boosters, changing pads,playards, and soothers for the three months ended September 28, 2019 as compared to the three months ended September 29, 2018. However, these increases were offset by the negative impact of increased tariffs imposed on goods imported into the United States from China that led to higher retail price points that resulted in softened demand and a decline in our mid-tier and international sales were affected by fewer channels and a stronger dollar.infant safety products.

 

Cost of goods sold includes cost of the finished product from suppliers, tariffs/duties on certain imported items, freight-in from suppliers, and miscellaneous charges. The components of cost of goods sold remained substantially the same for the quarter ended SeptemberMarch 28, 20192020 as compared to the quarter ended September 29, 2018.March 30, 2019.

 

Gross profit decreased 7.5%7.0% from $13,611$13,450 for the three months ended September 29, 2018March 30, 2019 to $12,595$12,503 for the three months ended SeptemberMarch 28, 2019. Gross profit as a percent of net sales declined slightly from 31.1% for the three months ended September 29, 2018 to 30.3% for the three months ended September 28, 2019. Gross profit dollars declined principally due to lower sales and increased tariffs that were offset only in part by increased wholesale prices, a shift in sales mix, and the decline in value of foreign currency sales.2020. Gross margin as a percent of net sales declined from 31.6% for the three months ended March 30, 2019 to 31.0% for the three months ended March 28, 2020. Gross profit declined due to increased tariffs, a shiftreduced sales. Gross margin declined primarily due to higher closeout sales in sales mix, andpart due to the decline in valueliquidation of foreign currency sales.inventory associated with the closure of our UK warehouse.

 

General and administrative expenses increased 9.6%decreased 13.1% from $7,623$9,379 for the three months ended September 29, 2018March 30, 2019 to $8,353$8,147 for the three months ended SeptemberMarch 28, 2019.2020. General and administrative expenses increaseddeclined from 17.4%22.0% of net sales for the three months ended September 29, 2018March 30, 2019 to 20.1%20.2% of net sales for the three months ended SeptemberMarch 28, 2019.2020. The decline in dollars and as a percent of sales was primarily due to the Company’s restructuring activities in the first quarter that included a reduction in work force and other cost reductions partially offset by severance costs as well as cost reductions from the previous fiscal year.

Selling expenses increased 2.7% from $3,353 for the three months ended March 30, 2019 to $3,444 for the three months ended March 28, 2020. Selling expenses also increased as a percent of net sales from 7.9% for the three months ended March 30, 2019 to 8.5% for the three months ended March 28, 2020. The increase in selling expense dollars and as a percent of sales was primarily attributable to $284 in legal settlementincreased cooperative advertisements and freight out costs in the three months ended September 28, 2019 while the three months ended September 29, 2018 included a one-time $535 adjustment to decrease the allowance for bad debt due to a partial recovery from the TRU bankruptcy.

Selling expenses decreased 1.7% from $3,658 for the three months ended September 29, 2018 to $3,597 for the three months ended September 28, 2019. Selling expenses increased as a percent of net sales from 8.3% for the three months ended September 29, 2018 to 8.7% for the three months ended September 28, 2019. The decrease in selling expense dollars is attributable to lower sales. The increase as a percent of sales for the three months ended September 28, 2019this year as compared to the three months ended Setember 29, 2018 was primarily attributable to increased cooperative advertisements and consumer advertisement primarily for new product launches and on-line marketing initiatives as compared to the three months ended September 29, 2018.March 30, 2019.

Depreciation and amortization decreased 9.2%increased 3.2% from $1,012$937 for the three months ended September 29, 2018March 30, 2019 to $919$967 for the three months ended SeptemberMarch 28, 2019. The decrease2020. Depreciation in the three months ended March 28, 2020 included $125 of accelerated depreciation and amortization was attributable to lower capital investment over the past year.on certain disposed assets.

 

Interest expense increased 6.5%12.9% from $1,118$1,249 for the three months ended September 29, 2018March 30, 2019 to $1,191$1,410 for the three months ended SeptemberMarch 28, 2019.2020. Interest expense increased due to higherprimarily as a result of the write off of $266 of previously unamortized prepaid finance fees associated with the reduction in the total revolver commitments under its Bank of America credit facility. Excluding the write off, interest expense decreased primarily as a result of lower debt levels and increasedthe impact of lower interest rates in the quarter partially offset by higher average interest margins under our amended credit facilities.

 

For the three months ended September 29, 2018,March 30, 2019, we recorded an $82 provisiona $70 tax benefit for income taxes on $200$1,468 of pretax income,loss, reflecting an estimated 41.0%4.8% tax rate for the quarter. For the three months ended SeptemberMarch 28, 2019,2020, we recorded a $195 provision$255 tax benefit for income taxes on $1,465 of pretax loss. loss, reflecting an estimated 17.4% tax rate for the quarter. The provision for income tax rate for the three months ended SeptemberMarch 28, 2020 included a $216 discrete valuation allowance charge for nondeductible interest expense. The tax rate for the three months ended March 30, 2019 included a $311$313 discrete valuation allowance charge for nondeductible interest expense.

 

Nine Months ended September 28, 2019 compared with Nine Months ended September 29, 2018

Net sales decreased 2.3% from $133,571 for the nine months ended September 29, 2018 to $130,486 for the nine months ended September 28, 2019 due mainly to the fact that the nine months ended September 29, 2018 included $2,954 of sales to Babies R Us, a subsidiary of Toys R Us (“TRU”), that did not recur in the nine months ended September 28, 2019 as a result of the liquidation of TRU in 2018. For the nine months ended September 28, 2019, sales to our top four customers increased by 6.5% over the prior year period and sales increased across several of our product categories such as in gates, potty, strollers, changing pads, and soothers. However, these increases were offset by the negative impact of increased tariffs imposed on goods imported into the United States from China that led to higher retail price points that resulted in softened demand and a decline in our mid-tier and international sales were affected by fewer channels and a stronger dollar.

Cost of goods sold includes cost of the finished product from suppliers, tariffs/duties on certain imported items, freight-in from suppliers, and miscellaneous charges. The components of cost of goods sold remained substantially the same for the nine months ended September 28, 2019 as compared to the nine months ended September 29, 2018.

Gross profit decreased 4.0% from $42,597 for the nine months ended September 29, 2018 to $40,887 for the nine months ended September 28, 2019. Gross margin as a percent of net sales decreased from 31.9% for the nine months ended September 29, 2018 to 31.3% for the nine months ended September 28, 2019. Gross profit dollars declined principally due to lower sales and increased tariffs that were offset only in part by increased wholesale prices, a shift in sales mix, and the decline in value of foreign currency sales. Gross margin as a percent of net sales declined due to increased tariffs, a shift in sales mix, and the decline in value of foreign currency sales.

General and administrative expenses decreased 11.3% from $29,587 for the nine months ended September 29, 2018 to $26,255 for the nine months ended September 28, 2019.  General and administrative expenses decreased from 22.2% of net sales for the nine months ended September 29, 2018 to 20.1% of net sales for the nine months ended September 28, 2019.  The decrease in dollars and as a percent of sales was primarily attributable to a non-recurring $1,813 increase in our allowance for bad debts due to the liquidation of TRU’s U.S. assets in the nine months ended September 29, 2018 as well as lower labor and other costs as a result of cost reduction actions taken in the three months ended March 30, 2019.

Selling expenses increased 16.5% from $9,427 for the nine months ended September 29, 2018 to $10,981 for the nine months ended September 28, 2019. Selling expenses also increased as a percent of net sales from 7.1% for the nine months ended September 29, 2018 to 8.4% for the nine months ended September 28, 2019. The increase in selling expense dollars and as a percent of net sales for the nine months ended September 28, 2019 was primarily attributable to increased cooperative advertisements and consumer advertisement costs primarily for new product launches and on-line marketing initiatives as compared to the nine months ended September 29, 2018, which also included a larger component of direct import sales.

Depreciation and amortization decreased 9.0% from $3,087 for the nine months ended September 29, 2018 to $2,808 for the nine months ended September 28, 2019. The decrease in depreciation was attributable to the decline in capital investment primarily over the past year.

Interest expense increased 13.1% from $3,300 for the nine months ended September 29, 2018 to $3,733 for the nine months ended September 28, 2019.  The increase in interest expense was primarily attributable to higher debt levels, increased interest rates under our new credit facilities. Interest expense for the nine months ended September 29, 2018, included a write off of $518 of previously unamortized prepaid finance fees associated with the repayment of existing debt from the proceeds of our June 2018 refinancing.

For the nine months ended September 29, 2018, we recorded a $513 benefit for income taxes on $2,804 of pretax loss, reflecting an estimated 18.3% tax rate. For the nine months ended September 28, 2019, we recorded a $392 provision for income taxes on $2,890 of pretax loss. The provision for income taxes for the nine months ended September 28, 2019, included a $805 discrete valuation allowance charge for nondeductible interest expense.

Liquidity and Capital Resources

 

We fund our operations and working capital needs through cash generated from operations and borrowings under our credit facilities.facility.

In our typical operational cash flow cycle, inventory is purchased in U.S. dollars to meet expected demand plus a safety stock. Because the

The majority of our suppliers are based ininventory is sourced from Asia inventorywhich takes fromapproximately three to four weeks to arrive from Asia toat the various distribution points we maintain in the United States and Canada, and the United Kingdom. Paymentpayment terms for these vendors are approximately 60-75 days from the date the product ships from Asia and therefore we are generally paying for the product a short time after it is physically received in the United States.Asia. In turn, sales to customers generally have payment terms of 60 days, resulting in an accounts receivable and increasing the amount of cash required to fund working capital. To bridge the gap between paying our suppliers and receiving payment from our customers for goods sold, we rely on our credit facilities.facility.

16

 

The majority of our capital expenditures are for tools and molds related primarily to new product introductions. We receive indications from retailers generally near the middle of each year as to what products they will be taking into their product lines for the upcoming year. Based on these indications, we will then acquire the tools and molds required to build and produce the products. In most cases, the payments for the tools are spread out over a three to four month period.

 

For the ninethree months ended SeptemberMarch 28, 2019,2020, net cash provided by operating activities totaled $1,142 primarily due to a reduction in accounts receivable and inventory during the year offset by a decrease in accounts payable and accrued expenses. Net cash provided by operating activities for the nine months ended September 29, 2018 was $5,444$4,887 primarily due to a reduction in inventory offset byand accounts receivable. Net cash used in operating activities for the three months ended March 30, 2019 was $7,519 primarily due to the paydown of accounts payable from higher inventory purchases in the previous fiscal quarter in advance of a reductionpotential further increase in accounts payable.tariffs.

 

For the ninethree months ended SeptemberMarch 28, 2020, net cash used in investing activities was approximately $245. For the three months ended March 30, 2019, net cash used in investing activities was approximately $1,913. For the nine months ended September 29, 2018, net$812.

Net cash used in investingfinancing activities was $2,644. The company reduced its investment in capital expenditures inapproximately $4,523 for the ninethree months ended SeptemberMarch 28, 2019.

2020 reducing borrowings on our credit facilities to fund inventory purchases and accounts receivable. Net cash provided by financing activities was approximately $828$8,672 for the ninethree months ended September 28,March 30, 2019 and reflected borrowings on our credit facilities primarily to reduce supplier payables. Net cash used by financing activities was approximately $2,554 for the nine months ended September 29, 2018, reflecting repayments on our credit facilities with funds generated from operating activities.fund inventory purchases and accounts receivable.

 

Based primarily onPrimarily as a result of the above factors, net cash decreasedincreased for the ninethree months ended SeptemberMarch 28, 20192020 by $62,$298, resulting in a cash balance of approximately $659$693 at SeptemberMarch 28, 2019.2020.

Capital Resources

 

In addition to operating cash flow, we also rely on our asset-based revolving credit facility with Bank of America, N.A. and our term loan agreement with Pathlight Capital to meet our financing requirements, which are subject to changes in our inventory and account receivable levels. We regularly evaluate market conditions, our liquidity profile, and various financing alternatives for opportunities to enhance our capital structure. As discussed below, on November 1, 2019, we negotiated amendments to our credit agreement and term loan agreement to provide additional flexibility.

 

IfAs discussed above, we have worked with our lenders to address the potential impact of the COVID-19 pandemic on our cash flow and access to funding under our credit facility. However, if we are unable to meet our current financial projections,forecast, experience a more severe impact from the COVID-19 pandemic on our business than expected, do not adequately control expenses, or adjust our operations accordingly, we may continue to experience constraints on our liquidity and may not meet the requirements under our credit agreementfinancial and term loan agreement to maintain a specified level of availability.  If our availability drops below specified levels, we will be required to meet certain financialother covenants under our credit agreementfacility and term loan agreement as discussed below.agreements, which could impact our availability. There is no assurance that we will meet all of our financial or other covenants in the future, or that our lenders will grant waivers or agree to amend the terms of our agreements with them if there are covenant violations. Therefore, in light of our current liquidity constraints,In such case, we may be required to seek to raise additional funds through debt or equity financings, restructure our existing debt, engage in strategic collaborations, and/or a strategic transaction that is in the best interest of our stockholders. Any such financing or strategic transaction could result in significant dilution to our existing stockholders, depending on the terms of the transaction. While we have engaged a strategic advisor to assist us in identifying and evaluating potential strategic transactions, ifIf we are unable to identify a strategic transaction, raise additional funds, and/or restructure our existing debt, our operations could be limited and we may not be able to meet all of our obligations under our credit agreementfacility and term loan agreement.

 

Based on past performance and current expectations, we believe that our anticipated cash flow from operations and availability under our existing credit facilitythe Restated BofA Agreement are sufficient to fund our working capital, capital expenditures and debt service requirements for at least the next 12 months.

 

Credit Facilities

 

On June 28, 2018, the CompanyWe and our wholly owned subsidiary, Summer Infant (USA), Inc., as borrowers, entered intoand certain of our subsidiaries as guarantors, are parties to a Second Amended and Restated Loan and Security Agreement with Bank of America, N.A., as agent, the financial institutions party to the agreementthat provides for a $48,000 asset-based revolving credit facility (as it may be amended from time to time, as lenders, and certain subsidiariesthe "Restated BofA Agreement"). The below discussion of the Company as guarantors (as amended, the “Restated BofA Agreement”). The Restated BofA Agreement replacedreflects the Company’s prior credit facility with Bankterms of America, and providesthe most recent amendment executed in April 2020. See Note 8 to our condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for a $60,000, asset-based revolving credit facility, with a $5,000 letterdescription of credit sub-line facility. The totalthe April 2020 amendments. Total borrowing capacity under the Restated BofA Agreement is based on a borrowing base, which is defined as 85% of eligible receivables plus the lesser of (i) 70% of the value of eligible inventory or (ii) 85% of the net orderly liquidation value of eligible inventory, less applicable reserves. The scheduled maturity date of loansLoans under the Restated BofA Agreement isare scheduled to mature on June 28, 2023 (subject to customary early termination provisions).

On March 25, 2019, the Company and Summer Infant (USA), Inc., as borrowers, entered into Amendment No. 1 to the Restated BofA Agreement that modified the definitions of Capital Lease, EBITDA, Eligible Account and Revolver Borrowing Base in the Restated BofA

Agreement in order to account for FASB mandated changes to lease accounting standards and provide additional financing flexibility to the Company. On November 1, 2019, the Company and Summer Infant (USA), Inc., as borrowers, entered into Amendment No. 2 to the Restated BofA Agreement (“BofA Amendment”).  The BofA Amendment amended the terms of the Restated BofA Agreement to, among other things, (a) increase the applicable margins on base rate and LIBOR revolver loans by 50 basis points, (b) modify the definition of Financial Covenant Trigger Amount so that the amount is (i) $4,000,000 through January 15, 2020, (ii) from January 16, 2020 through March 31, 2020, the amount will be (A) $4,000,000 or (B) $5,000,000 if the Company is not in compliance with certain covenants, and (iii) from and after April 1, 2020, $5,000,000; and (c) require that the Company engage a financial advisor to assist with providing a weekly, 13-week cash flow forecast.

All obligations under the Restated BofA Agreement are secured by substantially all the assets of the Company, including a first priority lien on accounts receivable and inventory and a junior lien on certain assets subject to the term loan lender’slender's first priority lien described below. Summer Infant Canada Limitedbelow, and Summer Infant Europe Limited,certain of our subsidiaries of the Company, are guarantors under the Restated BofA Agreement. Proceeds from the loans were used to satisfy existing debt, pay fees and transaction expenses associated with the closing of the Restated BofA Agreement and may be used to pay obligations under the Restated BofA Agreement, and for lawful corporate purposes, including working capital.guarantors.

 

Loans under the Restated BofA Agreement bear interest, at the Company’sCompany's option, at a base rate or at LIBOR with a LIBOR floor of 0.75%, plus applicable margins based on average quarterly availability under the Restated BofA Agreement. Interest payments are due monthly, payable in arrears. The Company isWe are also required to pay an annual non-use fee on unused amounts, as well as other customary fees as are set forth in the Restated BofA Agreement. The Restated BofA Agreement contains customary affirmative and negative covenants and certain financial covenants. Among other restrictions, the Company is restricted in its ability to incur additional debt, make acquisitions or investments, dispose of assets, or make distributions unless in each case certain conditions are satisfied. Through the end of fiscal 2020, the Company is required to achieve (i) a minimum net sales amount for each three consecutive months, measured at the end of each month, and (ii) a trailing 12-month minimum adjusted EBITDA amount, measured at the end of each month. In addition, if availability falls below a specified amount, a springing covenant would be in effect requiring the Company to maintain a fixed charge coverage ratio at the end of each fiscal month of at least 1.0 to 1.0 for the twelve-month period then ended.

 

The Restated BofA Agreement also contains customary events

17

As of default, including a cross default withMarch 28, 2020, the Term Loan Agreement or the occurrence of a change of control. In the event of a default, the lenders may declare all of the obligations of the Companyinterest rate for base-rate loans and its subsidiariesLIBOR-rate loans under the Restated BofA Agreement immediately duewere 5.0% and payable. For events of default relating to insolvency and receivership, all outstanding obligations automatically become due and payable without any action on3.50%, respectively. At March 28, 2020, the part of the lenders.

As of September 28, 2019, under the Restated BofA Agreement, the rate on base-rate loans was 6.25% and the rate on LIBOR-rate loans was 4.375%. The amount outstanding on the Restated BofA Agreement at SeptemberMarch 28, 20192020 was $32,000. Total$28,063, total borrowing capacity at September 28, 2019 was $38,852$33,689, and borrowing availability was $6,852.

$5,626.

Term Loan Agreement.  On June 28, 2018, the Company We and our wholly owned subsidiary, Summer Infant (USA), Inc., as borrowers, entered intoand certain of our subsidiaries as guarantors, are parties to a Term Loan and Security Agreement (the “Term Loan Agreement”) with Pathlight Capital LLC, as agent, each lenderpursuant to which we received a $17,500 term loan (as it may be amended from time to time, the "Term Loan Agreement"). The below discussion of the Term Loan Agreement reflects the terms of the most recent amendment executed in April 2020. See Note 8 to our condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for a partydescription of the April 2020 amendments. In connection with the March 2020 amendment to the Term Loan Agreement, and certain subsidiariesprincipal payments on the term loan were suspended for 2020 have been suspended, to resume in March 2021. In addition, the term loan began to accrue PIK (payment in kind) interest at an annual rate of 4.0% in March 2020, which interest will become payable upon repayment of the Company as guarantors, providing for a $17,500 term loan (the “Term Loan”). Proceeds fromor earlier upon the Term Loan were used to satisfy existing debt, pay fees and transaction expenses associated with the closingoccurrence of the Term Loan and may be used to pay obligationscertain events. The term loan matures on June 28, 2023. Obligations under the Term Loan Agreement and for lawful corporate purposes, including working capital.are also subject to a prepayment penalty if the term loan is repaid prior to the third anniversary of the closing of the term loan. The Term Loanterm loan is secured by a lien on certain assets of the Company, including a first priority lien on intellectual property, machinery and equipment, and a pledge of (i) 100% of the ownership interests of domestic subsidiaries and (ii) 65% of the ownership interests in certain foreign subsidiaries of the Company, and a junior lien on certain assets subject to the liens under the Restated BofA Agreement described above. The Term Loan matures on June 28, 2023. Summer Infant Canada Limitedasset-based revolving credit facility, and Summer Infant Europe Limited,certain of our subsidiaries of the Company, are guarantors under the Term Loan Agreement. 

On March 25, 2019, the Company and Summer Infant (USA), Inc., as borrowers, entered into Amendment No. 1 to the Term Loan Agreement that modified definitions consistent with the amendment of the Restated BofA Agreement, and also modified the IP Advance Rate Reduction Amount definition in order to provide additional financing flexibility to the Company. On November 1, 2019, the Company and Summer Infant (USA), Inc., as borrowers, entered into Amendment No. 2 to the Term Loan Agreement (the “Term Loan Amendment”).  The Term Loan Amendment amended the terms of the Term Loan Agreement to, among other things, (a) amend the definition of Financial Covenant Trigger Amount to be consistent with the BofA Amendment, (b) amend the definition of IP Advance Rate Reduction to provide that the amount of reduction will be (i) zero through December 31, 2019, (ii) 5.0 percentage points from January 1, 2020 through March 30, 2020, provided the Company complies with certain covenants, and (iii) 10.0 percentage points on and after March 31, 2020; and (c) consistent with the BofA Amendment, require that the Company deliver engage a financial advisor to assist with providing a weekly, 13-week cash flow forecast.

The principal of the Term Loan is being repaid, on a quarterly basis, in installments of $219, with the first installment having been paid on December 1, 2018, until paid in full on termination. The Term Loan bears interest at an annual rate equal to LIBOR, plus 9.0%. Interest payments are due monthly, in arrears. Obligations under the Term Loan Agreement are also subject to restrictions on prepayment and a prepayment penalty if the Term Loan is repaid prior to the third anniversary of the closing of the Term Loan.guarantors.

 

The Term Loan Agreement contains customary affirmative and negative covenants and certain financial covenants that are substantially the same as the Restated BofA Agreement. In addition, if availability falls below a specified amount, then the Company must maintain a fixed charge coverage ratio at the end of each fiscal month of at least 1.0 to 1.0 for the twelve-month period then ended. The Term Loan Agreement also contains events of default, including a cross default with the Restated BofA Agreement or the occurrence of a change of control. In the event of a default, the lenders may declare all of the obligations of the Company and its subsidiaries under the Term Loan Agreement immediately due and payable. For events of default relating to insolvency and receivership, all outstanding obligations automatically become due and payable without any action on the part of the lenders.described above.

 

As of SeptemberMarch 28, 2019,2020, the interest rate on the Term Loan was 11.13%.10.6% of cash interest and 4.0% of PIK interest. The amount outstanding on the Term Loan at SeptemberMarch 28, 20192020 was $16,625.$16,406.

ITEM 3.Quantitative and Qualitative Disclosures About Market Risk

ITEM 3.Quantitative and Qualitative Disclosures About Market Risk

 

As a smaller reporting company, as defined by Rule 12b-2 of the Exchange Act and in Item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this Item.

ITEM 4.Controls and Procedures

ITEM 4.Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

As required by Rule 13a-15(b) under the Securities Exchange Act of 1934, as of the end of the period covered by this Quarterly Report on Form 10-Q, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of our disclosure controls and procedures, as of SeptemberMarch 28, 2019.2020. Our Chief Executive Officer and Chief Financial Officer have concluded, based on this evaluation, that our controls and procedures were effective as of SeptemberMarch 28, 2019.2020.

 

Changes in Internal Control Over Financial Reporting

 

There was no change in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

18

PART II.  OTHER INFORMATION

ITEM 1.Legal Proceedings

ITEM 1.Legal Proceedings

 

The Company is a party to various routine claims, litigation and administrative complaints incidental to its business, including claims involving product liability, employee matters and other general liability claims, most of which are covered by insurance. We are not aware of any such proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, results of operations or financial condition.

ITEM 1A.Risk Factors

ITEM 1A.Risk Factors

 

There have been no material changes from the risk factors previously disclosed in Part I, Item 1A, “Risk Factors,” of our 20182019 Form 10-K, other than the following:

The recent COVID-19 pandemic and Part II, Item 1A, “Risk Factors,resulting worldwide economic conditions are adversely affecting, and may continue to adversely affect, our operations, financial condition, results of operations and cash flows.

In late 2019, a novel strain of coronavirus, COVID-19, was identified in China and has since spread globally and was declared a pandemic by the World Health Organization in March 2020. The COVID-19 pandemic has negatively impacted the global economy, disrupted global supply chains and created significant volatility and disruption of financial markets. We began to see an impact from the COVID-19 on our results of operations at the end of March, and we expect it to continue to adversely affect our business in the short term and potentially in the long term. The pandemic exposes us to a number of risks, including the following:

·Operational risks. As previously disclosed, we experienced some supply chain disruption in the first quarter as most of our product is sourced from China, which experienced widespread shutdowns in response to the COVID-19 outbreak. While we have seen production from China returning to normal levels, if there is another outbreak of COVID-19 in China, our supply chain could again be disrupted. Our suppliers located in other countries may also experience shutdowns due to COVID-19 that may impact our supply chain, as currently is the case with our supplier in Mexico.

In the U.S., we have continued to operate our distribution center in California, as products are considered “essential.While we have implemented additional safety measures for our workers in the distribution center, we may be required to temporarily close the facility if there are any confirmed cases of COVID-19 at the facility, which would impact our Quarterly Reportability to timely ship product to our customers.

·Customer-related risks. In response to the COVID-19 pandemic, some of our customers have had to close retail stores. As stores reopen, we expect that orders from these customers will return to a more normal level, however we cannot predict when such reopenings will occur, or if demand from consumers will be at the same level as it was prior to the COVID-19 pandemic. To the extent these customers, especially our mid-size and smaller customers experience financial difficulties as a result of the pandemic, we may see these customers permanently close stores, reduce orders, or file for bankruptcy, thus impacting sales.

In addition to the specific risks to our business noted above, we will also be subject to the long-term effects the COVID-19 pandemic may have on the U.S. economy as a whole. The U.S. is experiencing unprecedented unemployment and a possible economic recession that would likely impact consumer discretionary spending, and therefore demand for our products.

In addition to the risks noted above, the COVID-19 pandemic may also heighten other risks described in our 2019 Form 10-Q for10-K. The magnitude of the quarter ended March 30, 2019.impact of the COVID-19 pandemic will be determined by the length of time that the pandemic continues, and while government authorities’ measures relating to the pandemic may be relaxed as the pandemic abates, these measures may be reinstated as the pandemic continues to evolve.

ITEM 2.Unregistered Sales of Equity Securities and Use of Proceeds.

ITEM 2.Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

ITEM 3.Defaults Upon Senior Securities

ITEM 3.Defaults Upon Senior Securities

 

None.

19

ITEM 4.Mine Safety Disclosures

ITEM 4.Mine Safety Disclosures

 

Not applicable.

ITEM 5.Other Information.

 

ITEM 5.Other Information.On March 24, 2020, the Company and Summer Infant (USA), Inc., as borrowers, and certain of the Company’s subsidiaries as guarantors entered into a letter agreement with Pathlight Capital LLC, as agent, regarding the Term Loan Agreement to correct an error in the definition of “IP Advance Rate” as set forth in March 2020 amendment to the Term Loan Agreement. A copy of the letter agreement is filed herewith as Exhibit 10.6 and incorporated herein by reference.

 

None.Due to the COVID-19 pandemic, the Company currently anticipates that its 2020 annual meeting of stockholders (the “2020 Annual Meeting”) will be held on September 9, 2020. Because the date of the 2020 Annual Meeting represents a change of more than 30 days from the anniversary of the Company’s 2019 annual meeting of stockholders, in accordance with Rule 14a-5(f) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company is informing stockholders of this change.

The time and location of the 2020 Annual Meeting will be specified in the Company’s proxy statement for the 2020 Annual Meeting. Because the date of the 2020 Annual Meeting has been changed by more than 30 days from the anniversary of the 2019 annual meeting, new deadlines have been set for submission of proposals by stockholders intended to be included in the Company’s proxy statement for the 2020 Annual Meeting.

Pursuant to Rule 14a-8 under the Exchange Act, a stockholder intending to present a proposal to be included in the proxy statement for the 2020 Annual Meeting must deliver a proposal in writing to our principal executive offices no later than a reasonable time before we begin to print and mail the proxy materials for the 2020 Annual Meeting. Such proposal must also comply with the applicable requirements as to form and substance established by the Securities and Exchange Commission if those proposals are to be included in the proxy statement and form of proxy. Accordingly, the new deadline for submission of proposals to be included in the proxy statement for the 2020 Annual Meeting is July 11, 2020.

The Company’s Bylaws set forth advance notice procedures with regard to other stockholder proposals, including nominations for the election of directors and business proposals to be brought before an annual meeting of stockholders by any stockholder (other than matters included in our proxy materials in accordance with Rule 14a-8 under the Exchange Act). With respect to the 2020 Annual Meeting, such notice will be considered timely if we receive notice of such proposed director nomination or the proposal of other business at our corporate offices in Woonsocket, Rhode Island, not earlier than the close of business on June 11, 2020 and not later than the close of business on July 11, 2020.

ITEM 6.Exhibits

ITEM 6.Exhibits

 

The exhibits listed in the Exhibit Index immediately preceding the signature page hereto are filed as part of this Quarterly Report on Form 10-Q.

20

EXHIBIT INDEX

 

Exhibit No.

Description

31.1

3.1

Amended and Restated Certificate of Incorporation, as amended (Incorporated by reference to Exhibit 3.1 to the Registrant’s Annual Report on Form 10-K filed on March 18, 2020)

10.1+*Amendment to Engagement Letter, dated February 28, 2020, between Summer Infant, Inc. and Winter Harbor LLC
10.2*Amendment No. 3 to Second Amended and Restated Loan and Security Agreement, dated as of January 17, 2020, among Summer Infant, Inc. and Summer Infant (USA), Inc., as borrowers, the guarantors from time to time party thereto, the financial institutions from time to time party thereto as lenders, and Bank of America, N.A., as agent for the lenders (Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on January 17, 2020)
10.3*Amendment No. 3 to Term Loan and Security Agreement, dated as of January 17, 2020, among Summer Infant, Inc. and Summer Infant (USA), Inc., as borrowers, the guarantors from time to time party thereto, the financial institutions from time to time party thereto as lenders, and Pathlight Capital LLC, as agent for the lenders (Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on January 17, 2020)
10.4*Amendment No. 4 to Second Amended and Restated Loan and Security Agreement, dated as of March 10, 2020, among Summer Infant, Inc. and Summer Infant (USA), Inc., as borrowers, the guarantors from time to time party thereto, the financial institutions from time to time party thereto as lenders, and Bank of America, N.A., as agent for the lenders (Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on March 12, 2020)
10.5*Amendment No. 4 to Term Loan and Security Agreement, dated as of March 10, 2020, among Summer Infant, Inc. and Summer Infant (USA), Inc., as borrowers, the guarantors from time to time party thereto, the financial institutions from time to time party thereto as lenders, and Pathlight Capital LLC, as agent for the lenders (Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on March 12, 2020)
10.6+Letter Agreement, dated March 24, 2020, among Summer Infant, Inc. and Summer Infant (USA), Inc., as borrowers, the guarantors from time to time party thereto, the financial institutions from time to time party thereto as lenders, and Pathlight Capital LLC, as agent for the lenders
10.7+*Amendment No. 5 to Second Amended and Restated Loan and Security Agreement, dated as of April 29, 2020, among Summer Infant, Inc. and Summer Infant (USA), Inc., as borrowers, the guarantors from time to time party thereto, the financial institutions from time to time party thereto as lenders, and Bank of America, N.A., as agent for the lenders
10.8+*Letter Agreement, dated April 29, 2020, among Summer Infant, Inc. and Summer Infant (USA), Inc., as borrowers, the guarantors from time to time party thereto, the financial institutions from time to time party thereto as lenders, and Pathlight Capital LLC, as agent for the lenders
31.1+Certification of Chief Executive Officer

31.2

31.2+

Certification of Chief Financial Officer

32.1

32.1+

Section 1350 Certification of Chief Executive Officer

32.2

32.2+

Section 1350 Certification of Chief Financial Officer

101.INS

XBRL Instance Document

101.SCH

XBRL Taxonomy Extension Schema Document

21

 

101.CAL

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

XBRL Taxonomy Extension Labels Linkbase Document

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

*Portions of this exhibit have been omitted for confidential treatment pursuant to Regulation S-K, Item 601(b)(10).
+Filed herewith.

22

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Summer Infant, Inc.

Date: NovemberMay 12, 2019

2020

By:

/s/ Mark Messner

Stuart Noyes

Mark Messner

Stuart Noyes

Interim Chief Executive Officer

(Principal Executive Officer)

Date: NovemberMay 12, 2019

2020

By:

/s/ Paul Francese

Paul Francese

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

22


23